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This dissertation is dedicated to my mom. And for others with chronic illness who 
struggle to maintain quality of life. 
“Hope” is the thing with feathers – 
That perches in the soul – 
And sings the tune without the words – 
And never stops – at all – 
And sweetest – in the Gale – is heard – 
And sore must be the storm – 
That could abash the little Bird 
That kept so many warm 
I’ve heard it in the chilliest land – 
And on the strangest Sea – 
Yet, never in Extremity, 
It asked a crumb – of Me. 
Emily Dickinson (C.1891/1960) 
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ABSTRACT 
HEALTH-PROMOTING BEHAVIORS, HOPE, AND HEALTH-RELATED QUALITY 
OF LIFE IN PERSONS IMPACTED BY PARKINSON’S DISEASE 
AMY FORBES 
2017 
Objective:  The purpose of the study was to determine the relationship between hope, 
health-promoting behaviors, and health-related quality of life (HRQOL) in persons with 
Parkinson’s disease. 
Background: The incidence of Parkinson’s disease is high in Midwest and Northeast 
regions of the United States. Parkinson’s disease affects motor and non-motor symptoms 
and has a variety of complications. Parkinson’s disease is related to genetic and 
environmental factors. HRQOL decreases in Parkinson’s disease; thus, the effect of hope 
and health-promoting behaviors on health is crucial as the disease advances. 
Methods:  A descriptive correlational design was used to guide the study. A convenience 
sample of persons with Parkinson’s disease who completed three questionnaires was used 
to measure health-promoting behaviors and HRQOL while modifying for disease 
severity. 
Results: Exploratory factor analysis was used to examine dimensions of hope, health- 
promoting behaviors (HPLP), and HRQOL. Confirmatory factor analysis determined 
goodness of fit for the structure of the study data.  The construct reliability of the 
xiii 
confirmed factor structure model showed an adequate inter-item consistency (Cronbach’s 
alpha 0.70, QOL = .792, HPLP = .857, and hope = .844). After meeting the assessment of 
the reliability test, convergent validity, discriminant validity and confirmation of model 
fit of the factor model, a summated scale or a composite variable was created. The 
summated scale variables met five assumptions of the multivariate regression method to 
assess for appropriateness of method used. Finally, a path analysis was constructed where 
together hope and HPLP explained about 62% of the variation of scores within the 
dependent measure in HRQOL. Hope became non-significant statistically, with the 
inclusion of HPLP. Effects of varying stages of disease severity and its relation to the 
direct effects of hope and HPLP to the dependent measure in HRQOL was contemplated. 
 Conclusions: This study advances knowledge regarding the relationship between 
hope, HPLP, and HRQOL in persons with Parkinson’s disease. The increased knowledge 
raises awareness of the importance of hope and health-promoting behaviors despite 
various stages of disease severity. 
Key words:  hope, health-promoting behaviors, health-related quality of life, 
Parkinson’s disease, factor analysis
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
Phenomenon of Interest 
Parkinson’s disease is a chronic, progressive neurological disease that afflicts 
more than one million Americans, a number expected to double by 2030 (National 
Parkinson’s Foundation [NPF], 2015). The main symptoms of Parkinson’s disease 
include bradykinesia, rigidity, and tremors. These motor symptoms respond well to 
treatment in the early stages, but the disease also has non-motor symptoms and is 
progressive with a variety of complications (Winter et al., 2010). Parkinson’s disease is 
the second-most common neurodegenerative disorder, after Alzheimer’s disease (NPF, 
2015). About 60,000 new cases of Parkinson’s disease are diagnosed each year in the 
United States, and this number does not include the large number of cases that go 
undetected (Parkinson’s Disease Foundation [PDF], 2016). The incidence of Parkinson’s 
disease is projected to triple by 2050, an increase that is directly related to the aging 
population and the increased risk of developing Parkinson’s disease with age. Peak 
incidence of the disease is typically between 70 and 79 years of age, but four percent of 
persons with Parkinson’s disease have early onset, which is diagnosed before age 50 
(PDF, 2016). 
The Midwest and Northeast regions of the United States have a Parkinson’s 
disease belt with higher prevalence and incidence of the disease in a nonrandom 
distribution. These regions report that the rate of Parkinson’s disease is up to 10 times 
greater than other geographic areas in the United States. In addition, there is case 
clustering in the Midwest. Nebraska has the highest incidence of Parkinson’s disease in 
the United States, affecting 329.3 per 100,000 people. In addition, South Dakota, North 
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Dakota, Minnesota, and Iowa have the highest incidence of people with Parkinson’s 
disease in America. These rural states are also recognized for their high agriculture 
productivity and use of heavy insecticides and pesticides in farming areas (American 
Parkinson’s Disease Association [APDA], 2012).  According to the South Dakota 
Parkinson Foundation (2016) there are 3,000 persons in South Dakota that have 
Parkinson’s disease. 
 Both genetic and environmental factors contribute to the likelihood of contracting 
Parkinson’s disease. Although men are one-and-a-half times more likely to develop 
Parkinson’s than women, research is not conclusive about whether this difference is due 
to genetics, hormones, or behavioral differences (NPF, 2015). Two thirds of patients with 
Parkinson’s disease have no family history of the disease (Center for Disease Control 
[CDC], 2015). Having a first-degree relative with Parkinson’s, such as a parent or sibling, 
increases the risk of Parkinson’s disease by four percent to nine percent compared to the 
general population (NPF, 2015). Thirteen gene mutations are associated with Parkinson’s 
disease. Environmental factors alone do not cause Parkinson’s disease unless there is also 
a genetic risk. A common analogy relating the causative factors for Parkinson’s disease is 
that genetics is the gun, but something in the environment pulls the trigger (PDF, 2016). 
Exposure to pesticides, chemicals such as manganese, rural living, farming, and 
well water are all known environmental risks that increase the rate of Parkinson’s disease 
(NPF, 2015; Owens, 2008).  Ethnically similar individuals who are genetically 
susceptible to Parkinson’s disease reside in this area of the country (Wright Willis, 
Evanoff, Lian, Criswell, & Racette, 2010). For example, the Spellman-Muenter family in 
Iowa links 200 cases of Parkinson’s disease to kindred who have genes associated with 
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Parkinson’s disease (Gwinn, 2009). Furthermore, both the area of the country (which 
relates to the exposure of environmental toxins) and a person’s ethnicity (which increases 
genetic risk) may lead to an increase of Parkinson’s disease for people in the Midwest 
and Northeast regions of the United States.  
Health-Related Quality of Life 
Quality of life often decreases when a person goes through an experience as is 
threatened can a person understand the important connection between humanity and 
human dignity. Patients with Parkinson’s disease often lose dignity when they are no 
longer able to care for themselves, interact with their families, or participate in their 
communities, thereby rendering them without a sense of belonging. When people 
maintain health-related quality of life (HRQOL) and increased hope, they also maintain 
their dignity. According to the American Nurses Association (ANA, 2015), nurses are 
obligated to uphold the first provision of the Code of Ethics for nurses and act with 
compassion and appreciation for human dignity (p. 1). This underlying provision respects 
the patient’s basic needs, values, and lifestyle, and ultimately leads to an overall 
betterment of humanity. 
Parkinson’s disease is associated with daily physical limitations, compromised 
communication, and eventual decreased cognitive functioning. Parkinson’s disease 
affects more than physical functioning; it also contributes to psychosocial 
malfunctioning. According to Welsch et al. (2003), depression, anxiety, and decreased 
social interaction are common in patients with Parkinson’s disease. All of these factors 
may decrease HRQOL. Along with the decline in motor symptoms, non-motor 
symptoms, such as depression, anxiety, and cognitive impairment, as well as fatigue, 
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pain, sleep, and bladder problems, contribute to lower HRQOL (Kadastik-Eerme, 
Rosenthal, Paju, Muldmaa, & Taba, 2015). 
HRQOL includes the following domains: physical functioning, physical role, 
bodily pain, general health perceptions, vitality, social functioning, emotional 
functioning, and mental health (Sigstad, Stray-Pederson, & Froland, 2005). In contrast to 
acute diseases wherein a cure is the ultimate goal, the goal of treating Parkinson’s disease 
is to minimize symptoms and improve HRQOL. Welsch et al. (2003) developed a model 
for recognizing factors that affect quality of life in patients with Parkinson’s disease. 
These factors include a multitude of measures that contribute to quality of life for those 
with Parkinson’s disease, including physical function, mental/physical/emotional 
wellbeing, self-image, health related distress, cognitive function, communication, sleep 
and rest, eating, role function, energy/fatigue, and sexual function.  
The Japanese Association of Patients with Parkinson’s Disease found that patient 
education led to better HRQOL (Shimbo et al., 2004). In the Netherlands, researchers 
concluded that Parkinson’ s disease patients who have autonomic dysfunctions, nighttime 
sleep problems, and cognitive dysfunction are at risk for deterioration of HRQOL. 
Of all the determinants contributing to HRQOL, depression is the strongest and 
the most common factor associated with decreased HRQOL in patients with Parkinson’s 
disease (Kadastik-Eerme et al., 2002). Feelings of hopelessness are common in those who 
are clinically depressed (Abramson, Alloy, & Metalsky, 1989), and hopelessness 
concerning the future is one the main characteristics of depression (Beck, Rush, Shaw, & 
Emery, 1979). Therefore, having hope is pertinent to giving meaning and value to life; 
the contrary, the loss of hope, has been found to decrease quality of life (Rustoen, 1995). 
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Hope 
Hope is a positive belief that allows people with chronic illnesses to overcome 
devastating diseases and become survivors. Frankl, an Australian psychiatrist who spent 
years as a prisoner in concentration camps during World War II, describes an example of 
hope related to devastation. Frankl observed that if people lose hope, they do not live 
long. He believed people with hope have meaning in their lives, but if they have no hope, 
they have no meaning (Frankl, 1959).  
In a study of 96 newly diagnosed cancer patients in Norway, hope was found to 
be a coping strategy to enhance quality of life (Rustoen, 1995). Hope contributes 
positively to health and is healing for those going through a period of stress or loss. A 
hopeful mindset helps persons cope in order to attain higher quality of life (Farran, Herth, 
& Popovich, 1995). 
The concept of hope is essential for everyone, is applicable to all populations and 
all areas of life, and is vital for those suffering with a debilitating chronic disease like 
Parkinson’s. Nurses have the moral obligation to help their patients nurture hope when 
faced with illness and disease (Simpson, 2004). Travelbee (1971) describes nursing as an 
interactive process and notes hope is a future-oriented quality in which people look 
forward to a time when life will be meaningful. Hope is a positive, joyful expectation that 
something good is going to happen. In medicine, hope is essential to promoting health 
and healing. By better understanding the function of hope in healing, nurses can help 
restore their patients’ health.  
Hope is often seen as an action (Green, 1977) and inspires persons to take action 
to utilize health-promoting behaviors (Dufault & Martocchio, 1985). Participating in 
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health-promoting behaviors for persons with cancer improves their quality of life. Cancer 
survivors, compared to the public, do not participate in equal levels of exercise, eating 
healthy, and maintaining a healthy weight (Meraviglia, Stuifbergen, Parsons, & Morgan, 
2013). Nurses also must recognize the signs of hope and hopelessness in their patients’ 
actions, and respond accordingly. 
Health-Promoting Behaviors 
The social science of health promotion benefits the general public by teaching 
people to make better health choices (Ruth, 2015). According to McCutcheon (2015), 
health-promoting behaviors relate to the following sciences: biological, physical, 
psychosocial, and environmental.  The common goal is improving health. McCutcheon 
described empowerment, participation, and community as attributes of health-promoting 
behavior. McCutcheon concluded that health-promoting behaviors lack definition and 
application in nursing literature.  
Whitehead (2004) states nurses use terms like health promotion and health 
education interchangeably and the focus of health promotion should be more on 
community driven health reform, community empowerment, social objectives, and health 
policy. He criticizes some nursing theories for using a health education model and calling 
it health promotion.  
Other nurse researchers have also scrutinized nursing literature on the 
contextualization of the term health promotion. Kemppainen, Tossavainen, and Turunen 
(2012) consider the focus of health promotion in nursing to be on disease prevention and 
needs to be overhauled to a health promotion philosophy.  
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A few researchers relate their definition of health promotion and health-promoting 
behaviors back to the World Health Organization and the importance of exerting control 
over health and health determinants to improve health (WHO, 2015). Polvsen and Borup 
(2011) refer to health promotion as the combination as the social and political process to 
regulate health determinants and improve health and quality of life. The College of Public 
Health (2013) describe the improvement on individual, group, community and system 
changes to improve overall knowledge, skills, attitudes and health behaviors. 
Health-promoting behaviors are actions focused on developing levels of 
wellbeing and realizing health potential on an individual level, within families and 
communities, and throughout societies (Pender, 1987). Some examples of activities 
utilized for health promotion for persons with Parkinson’s disease relate to healthy 
eating/diet, physical activity/exercise, stress level, sleep, inner peace, and self-esteem 
(Fowler, 1997).  
Summary Hope, Health-Promoting Behaviors, and Health-Related Quality of Life  
The perspective of a person with respect to hope, health promotion, and HRQOL 
plays a pivotal role in engaging health-promoting behaviors for people with Parkinson’s 
disease and patient outcomes. Hope is foundational to healing and can empower people to 
choose health-promoting behaviors. Hope is related to action in empirical studies, and 
this action can parallel health-promoting behaviors (Fowler, 1997). Fowler’s (1997) study 
showed a positive relationship between hope and a health-promoting lifestyle in persons 
with Parkinson’s disease who completed the Herth Hope Index (HHI) and Health-
Promoting Lifestyle Profile II (HPLP II). The literature lacks further support on the 
association between hope and health-promoting behaviors. 
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The association between Parkinson’s disease and decreased HRQOL has been 
studied extensively worldwide (Caap-Ahlgren & Lannerheim, 2002; Haahr, Kirkevold, 
Hall, & Ostergaard, 2011; Leonardi et al., 2012; Miyashita et al., 20110; Post et al., 2011; 
Qin et al, 2009; Visser et al., 2009;  Weintraub, Moberg, Duda, Katz, & Stern, 2004; 
Winter et al. 2010a, 2010b, 2011).  However, there is limited research in the United 
States (Welsch et al., 2003). This creates a gap in the literature, given that the United 
States has the highest prevalence of Parkinson’s disease in the world. Knowledge gained 
in this study will provide insight into ways to improve health, health-promoting 
behaviors, and HRQOL for those with Parkinson’s disease. According to Pender, 
Murdaugh, and Parsons (2015) the purpose of nursing research is to create knowledge to 
enhance health. Enhancing health parallels easing the burden of disease.  
Based on the literature by Fowler’s (1997) there is a positive relationship between 
hope and a health-promoting lifestyle in persons with Parkinson’s disease who completed 
the Herth Hope Index (HHI) and Health-Promoting Lifestyle Profile II (HPLP II) but the 
literature lacks further support on the association between hope and health-promoting 
behaviors. Hope interventions have improved quality of life in persons with cancer 
(Herth, 2000). The literature shows that health-promoting behaviors in a variety of 
populations including persons with breast cancer, HIV, multiple sclerosis, polio, and 
Parkinson’s disease all relate to high levels of hope (Bouchard, 1992; Fowler, 1997; & 
Harrison, 1993). 
The effect hope and health-promoting behaviors play on HRQOL is critical 
because health is so much more than absence of disease. For persons with Parkinson’s 
disease and others with a chronic illness, health must be seen alongside a continuum with 
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disease. The severity of illness in Parkinson’s disease severely decreases HRQOL 
(Global Parkinson’s Disease Survey Steering Committee, 2002). Initiating hope and 
health-promoting behaviors can lessen the downward progression of the disease. By 
having stronger levels of hope and health-promoting behaviors, persons with Parkinson’s 
disease will be better equipped to manage as their disease progresses and maintain their 
level of health, despite disease.  
Purpose of the Study 
The purpose of this study is to examine the relationship between the concepts of 
hope, health-promoting behaviors, and HRQOL in people with Parkinson’s disease. The 
hypothesis is a stronger level of hope and health-promoting behaviors will correspond to 
a higher HRQOL, modifying for disease severity and progression.  
The aims of this study are as follows: (1) to conduct a comprehensive exploration of the 
relationships among hope, health-promoting behaviors, and HRQOL; (2) to test for a 
moderating effect of hope on the relationship between health-promoting behaviors and 
HRQOL; and (3) to explore the effect of disease severity on the relationship among hope, 
health-promoting behaviors, and HRQOL. 
Research Questions  
1. What is the level of hope in persons with Parkinson’s disease? 
2. What is the relationship between hope and health-promoting behaviors on HRQOL in 
persons with Parkinson’s disease? 
3. What is the relationship among hope, health-promoting behaviors, HRQOL, and 
disease severity? 
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Figure 1. Study framework. 
Research Hypotheses 
Three hypotheses are tested following the study framework. The first hypothesis 
(H1+) predicts that persons with Parkinson’s disease have hope. The second hypothesis 
(H2+) predicts that health-promoting behaviors will correspond to a stronger measure of 
hope, which signifies a positive relationship between hope and health promoting 
behaviors. Health-promoting behaviors and stronger level of hope are expected to lead to 
a positive impact on HRQOL. The final hypothesis (H3+) proposed that higher levels of 
hope and health promoting behaviors will correspond with higher HRQOL, modifying for 
disease severity and progression which is measured by the patient’s self-report in the 
Health-Promoting 
Behaviors 
Measured with Health- 
Promoting Lifestyle Profile  
(HPLP II) 
STRONGER HOPE 
Measured with Herth 
Hope Index (HHI) 
Higher HRQOL 
Measured with 
Parkinson’s Disease 
Questionnaire (PDQ8) 
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Hoehn and Yahr scale (see Appendix B). 
Significance of the Study and Nursing Perspective   
Some of the overarching goals of Healthy People 2020 include increasing the 
years of healthy life and the quality of life for all Americans (U.S. Department of Health 
and Human Services, 2012). Nurses can contribute to the future of healthcare by 
promoting health for those who suffer from Parkinson’s disease and other debilitating 
diseases. This goal is especially important in later stages of Parkinson’s disease when 
medical treatment and medication no longer help fight the disease, and the focus of 
treatment is to improve quality of life. An increase in the number of people with 
Parkinson’s disease will require an increased number of nurses to care for them. Nurses 
have an opportunity to help people cope with the wide variation of challenges from this 
incurable lifelong disease.  Race, education, and income are significant and independent 
factors when determining the level of disability for Parkinson’s disease patients. 
Researchers found health disparities in patients with Parkinson’s disease who are both 
African American and lower income. African Americans and those with lower 
socioeconomic status had progressed disease and further disability in disease 
management upon seeking treatment. These disparities lead to earlier loss of 
independence (“Parkinson’s Disparities,” 2010). 
A better understanding of the relationship among hope, health-promoting 
behaviors, and HRQOL will help nurses, patients, and caregivers promote a potential 
hope intervention and encourage health-promoting behaviors for those with Parkinson’s 
disease. Attributes of hope can increase coping mechanisms, which lead to improved 
quality of life. Nurses play a significant role in influencing hope and, therefore, quality of 
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life (Herth, 2000).  
Although the connection between hope and quality of life has been studied in 
people with cancer, it has not been studied in people with Parkinson’s disease. Herth 
(2000) established that quality of life improves in cancer patients who receive hope 
intervention, and Pender (1987, p.4) noted that one of the national health professional 
goals is to promote health for those persons with chronic diseases or disability. Although 
health-promoting behaviors and hope have been studied frequently in persons with 
chronic illnesses, the literature reveals that this relationship was examined once in 
persons with Parkinson’s disease (Fowler, 1997). Nurses are the leading section of health 
professionals; therefore, they have the opportunity to uphold national health promotion 
goals. Supporting a culture of health promotion is a significant role of nurses (Savage & 
Kub, 2009).  
Another significant role for nurses is to encourage hope. Watson’s Caring Model, 
written in 1988, describes instilling hope as part of the second carative factor of nursing 
(Watson, 2012). Nurses can integrate hope into their plan when caring for their patients. 
Nurses can also encourage patients to practice health-promoting behaviors influencing 
their overall health outcomes. Notably, by promoting health behaviors and encouraging 
hope, nurses show they value the HRQOL of persons with Parkinson’s disease in all 
settings. Enhancing hope for patients with Parkinson’s disease will, in turn, improve 
HRQOL and human dignity for those struggling with this disease.  
Definitions   
Theoretical Definition Hope. A multidimensional energy, always present and 
changing, which is described by a positive, yet unclear belief of reaching a future benefit 
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(Dufault & Martocchio, 1985, p. 380). Hope is an individualized future orientated 
experience that offers possibility and optimism despite uncertainty. 
Operational Definition Hope. Hope is always changing, particularly when 
overcoming life events such as chronic illnesses like Parkinson’s disease or aging. In this 
study, hope is determined by a measurement at a point in time on the Herth Hope Index 
(HHI) scale.  
Theoretical Definition Health-Related Quality of Life (HRQOL). HRQOL 
relates to an individual’s perception of their well-being related to disease and health 
status (Winter, 2010a). Dignity has also been noted as a fundamental component of 
quality of life (Manthorpe et al., 2010). In this study, quality of life is limited to HRQOL, 
which has many facets. The focus is on the following domains related to Parkinson’s 
disease: “mobility, activities of daily living, emotional well-being, stigma, social support, 
cognition, communication and bodily discomfort,” (Rodriguez-Violante et al., 2013, 
p.11).   
Operational Definition Health-Related Quality of Life (HRQOL). In this 
study the Parkinson’s Disease Questionnaire-8 item version (PDQ-8) will measure 
HRQOL and specifically the domains of “mobility, activities of daily living, emotional 
well-being, stigma, social support, cognition, communication and bodily discomfort,” 
(Rodriguez-Violante et al., 2013, p.11).   
Theoretical Definition Health-Promoting Behaviors. The World Health 
Organization (WHO, 2015) defines health promotion as “the process of enabling people 
to increase control over their health and its determinants, and thereby improve their 
health.” Health-promoting behaviors relate to “activities directed toward increasing the 
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level of well-being and actualizing the health potential of individuals, families, 
communities and societies” (Pender et al., 2015, p. 4). 
Operational Definition Health-Promoting Behaviors. In this study, health-
promoting behaviors will be measured using Pender’s Health-Promoting Lifestyle Profile 
II (HPLP- II). The scale for HPLP-II measures self-actualization, health responsibility, 
exercise, nutrition, interpersonal support, and stress management (Walker, Sechrist, & 
Pender, 1987). 
Theoretical Definition Parkinson’s Disease. Nearly 200 years ago, Dr. James 
Parkinson of London noted a phenomenon he called the shaking palsy. The first 
characteristic he noted included a tremor at rest, stooped posture, and a shuffling gait 
(Parkinson, 1817). Three classic signs of the disease are tremor at rest, rigidity, and 
slowness. Two of these three clinical manifestations are necessary for diagnosis 
(Bunting-Perry & Vernon, 2007).  
Operational Definition Parkinson’s Disease. Parkinson’s disease is a chronic 
progressive neurological disease with motor, non-motor, and neuropsychiatric symptoms, 
which mainly effects the elderly. Parkinson’s disease is characterized by a loss of 
dopamine in the brain (Bunting-Perry & Vernon, 2007). 
Theoretical Definition Disease Severity. Disease severity indicates the amount 
of disease in the body. In Parkinson’s disease the greater the amount of motor disability 
leads to greater disease severity. Disease severity does not indicate disease progression, it 
is only the statement of where the patient is rated at the current time (Bunting-Perry & 
Vernon, 2007).   
Operational Definition Disease Severity. Hoehn and Yahr (H&Y) staging 
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measures the disease severity of Parkinson’s disease in the study. The mildest stage with 
unilateral symptoms is H&Y 1. A wheelchair-bound or bed-ridden state is the most 
severe stage, which is H&Y 5 (Hoehn & Yahr, 1967).   
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CHAPTER 2: REVIEW OF LITERATURE 
Introduction 
The purpose of this study is to describe the relationship between hope, health-
promoting behaviors, and quality of life in people with Parkinson’s disease. The critical 
literature review provides a foundation for examining this relationship. The literature 
review begins with an examination of both the prevalence and health consequences of 
Parkinson’s disease. It synthesizes findings on the concepts of hope, health-promoting 
behaviors, and health-related quality of life (HRQOL). Literature was reviewed by 
concepts and in phases. The theoretical framework guiding the study is also described.  
Prevalence of and Health Cost Related to Parkinson’s Disease  
As the number of persons with Parkinson’s disease grows the costs of treating 
them also increases. The economic impact of Parkinson’s disease is an estimated $25 
billion per year in the United States (PDF, 2016). The financial burden for Parkinson’s 
disease patients combines direct costs and indirect costs of the disease, such as treatment, 
social security payments, lost income from work, and homecare. Medications alone cost 
an individual with Parkinson’s disease $2,500 a year, and therapeutic surgeries can cost 
around $100,000 dollars per patient (PDF, 2016).  
The highest prevalence of the disease in the United States is in Nebraska, 
followed by South Dakota (CDC, 2015). The heartland of America is well known for 
farming communities that heavily use insecticides and pesticides. Studies have noted the 
occupational risks of farming associated with Parkinson’s disease, illustrating that the 
risk of Parkinson’s disease rises with exposure to pesticides --(Kenborg, Lassen, Lander, 
& Olsen, 2012; Wright Willis, Evanoff, Lian, Criswell, & Racette, 2010). Common 
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pesticides are neurotoxic and can trigger changes in the brain that are similar to the loss 
of neurons in the brain and other pathological features that cause idiopathic Parkinson’s 
disease (Allen & Levy, 2013).  
The Agriculture Health Study also suggests that contact with pesticides increases 
the danger of Parkinson’s disease (Kamel et al., 2007). The study initially compared 
79,557 persons who applied pesticides in relation to self-reported Parkinson’s disease. 
Applying the chemical paraquat was associated with 87 prevalent cases of Parkinson’s 
disease. The odds ratio for the incidence of Parkinson’s disease for those that applied 
chemical compared to the cohort control was 2.3%, confidence interval: 1.2, 4.5, and p = 
.0009.  The study noted that certain chemicals may increase Parkinson’s disease risk, a 
premise that needs further investigation. A limitation of the study was the dependence on 
self-reporting of disease.  
A Danish study of gardeners exposed to pesticides concluded that an association 
between a small-dose exposure to pesticides and the risk for Parkinson’s disease could 
not be ruled out (Kenborg et al., 2012). The study of 3,124 male members of the Danish 
Union of Gardeners indicated a weak but dose-related association of pesticide exposure 
and diagnosis of Parkinson’s disease using hospital-registered data (Kenborg et al., 
2012). 
A number of studies over the past 25 years suggest well water contaminated with 
agricultural pesticides play a role in the etiology of Parkinson’s disease (Gatto et al., 
2009; Marder et al., 1998; Morano et al., 1994; Smargiassi et al., 1998; Wang, Fang, 
Cheng, Jiang, & Lin, 1993; Wechsler et al., 1991; Wong et al., 1991). Several of these 
reports were small, less than 100 cases and all were self-reported exposure to pesticides. 
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Gatto, Cockburn, Bronstein, Manthripragada, & Ritz (2009) found consuming 
well water contaminated by agricultural pesticides increases the relative risk of 
Parkinson’s disease. This study took place between 2001 and 2007 in Central Valley 
California, which is well known for its high agricultural activities. This study did not rely 
on self-reporting, but sampled the water for six different pesticides and compared to 
documented data. They completed a geographic system of controls and found 368 cases 
with Parkinson’s disease had consumed private well water 4.3 years longer than the 341 
controls enrolled in their study. The study supports consuming well water contaminated 
with pesticides has an associated risk of Parkinson’s disease.  
Summary 
As the population ages, the number of persons with Parkinson’s disease increases, 
and so does the financial burden of the disease (Achey et al., 2014). The financial loss 
and burden of Parkinson’s disease in cost of medicines and treatments does not compare 
to the emotional loss and suffering from disease. The growing number of persons with 
Parkinson’s disease is concerning, especially in the agricultural heartland of America 
where the disease prevalence and risk for the disease is already high compared to other 
areas of the United States (CDC, 2015; Kamel et al., 2007; PDF, 2016). 
Hope 
The key literature search for hope examined literature from the EBSCOhost 
database (incorporating the following databases CINAHL, MEDLINE, and PsychINFO). 
The years were limited from 2000 to 2017. Next, the search for terms hope and nursing 
were combined. Nursing was added to the search to decrease the number of articles, 
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which was focused on hope for a cure or hope for stem cells in Parkinson’s disease. 
Pertinent literature from earlier years was also included in the literature review.   
Hope first appeared in healthcare literature in the mid-1960s with a focus on 
spirituality (Lynch, 1965). Since then, many researchers have redefined hope. According 
to Erickson (1964), hope is part of the developmental process as the first stage of 
development, an outcome of basic trust versus mistrust, which is the basis for 
experiencing security with an attachment figure. The quality of the attachment experience 
contributes to later experiences of either hope or despair. An infant or young child’s 
attachment to a parental figure provides a foundation that can either encourage the child 
to hope or to despair. A good role model of hope can have a positive effect on a child’s 
development; even in situations promoting negative effects of home, however, an 
individual can choose to overcome any trust barriers developed in childhood to 
potentially yield an outcome of hope. Further studies showed that hope had a positive 
correlation with social support (Edwards, Ong, & Lopez, 2007; Heaven & Ciarrochi, 
2007; Mahat, Scoloveno, & Whelan, 2002; Yarcheski, Mahon & Yarcheski, 2001; Vacet 
et al., 2010).  
Critical literature on hope was identified by a concept analysis building on the 
work of Dufault and Martocchio (1985) who described hope in persons with cancer. 
Hope has two spheres: (1) generalized hope, where the end result is desired; and (2) 
particularized hope, which relates more to meaning in life. The two spheres can overlap. 
There are six dimensions of hope depicting experiences related to “affective, cognitive, 
behavioral, affiliative, temporal, and contextual” domains (Dufault & Martocchio, 1985, 
p. 381). Health practices, self-care agency, and health-promoting factors are positive 
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outcomes of hope and are consistent with Dufault and Martocchio’s conceptualization of 
hope (Canty-Mitchell, 2001; Mahat & Scoloveno, 2001; Mahat et al., 2002; Mahon et al., 
2004). 
Hope differs depending on the environment, and hope changes when illness 
strikes. The different attributes that enable people to hope allow hope to be a unique and 
ever-changing process. Several patterns in the language describing hope were identified. 
Concepts that appeared repeatedly were as follows: hope is future orientated, requires 
energy, is goal orientated, and contains an element of uncertainty (Amendolia, 2010; 
Dorcy, 2010; Lohne & Severinsson, 2004). Other terms related to hope that appeared in 
the literature were power, realism, meaningful, internal, intuitive, integrative, holistic, 
anticipation, realism, and essential for life (Amendolia, 2010; Dorcy, 2010). 
Duggleby et al. (2010) examined hope in 20 studies from a variety of countries in 
persons with different medical diagnoses. The authors described hope as being dynamic 
and future orientated, as well as being able to transcend possibilities and involve choice. 
Older and younger persons differed in their interactions with hope when suffering, but 
regardless of age, the 20 studies emphasized the importance of incorporating strategies to 
help those with chronic illness sustain hope. 
For those afflicted with Parkinson’s disease, the literature mentions a significant 
loss of self-esteem, which correlates to the need to promote hope, a health-promoting 
behavior, to improve self-esteem. Hope occurs when people have high self-esteem 
(Cantrell & Lupinacci, 2004; Heaven & Ciarrochi, 2007; Ritchie, 2001; Simon, Barakat, 
Patterson & Dampier, 2009; Vacek et al., 2010). Additionally, life satisfaction has a 
positive and statistically significant correlation with hope (Bronk, Hill, Lapsey, Talib & 
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Finch, 2007; Gilman, Dooley, & Florell, 2006; Hexdall & Huebner, 2007; Shoegren et 
al., 2006; Vacek et al., 2010; Valle et al., 2006; Wong & Lim, 2009).  
Empirical studies suggest that religious values help with coping and have an 
association with increased hope. Heaven & Ciarrochi (2007) studied 784 participants and 
found participants who had higher religious values also had higher levels of hope. Miller 
and Kelly (2005) also found an elevated level of hope and optimism in persons with 
religious values. Their study linked religion to better mental health and having more hope 
improved coping mechanisms. Another study of 126 low socioeconomic minorities 
reported that having hope directly relates to religious coping. This study examined diaries 
of adolescents and discovered having hope helped buffer stress (Roesch, Duangado, 
Vaughn, Aldridge, & Villodas, 2010).   
Hope is a construct that studies have shown to improve coping in multiple 
populations such as the elderly, those with cancer, spinal cord injury, mental illness, heart 
disease, and stroke (Bland & Darlington, 2002; Bluvol & Ford-Gilboe, 2004; Herth, 
1993; Farran et al., 1995; Lohne & Severinsson, 2004). Hope improves coping skills and 
adaptation capacities and does not decrease as age increases (Lieberman and Tobin, 
1983). In the elderly population, literature shows hope is an essential human need 
(Forbes, 1994).  
Herth studied hope in 125 patients with recurrent cancer receiving treatment. The 
study was a quasi-experimental design with three groups. The first group received a hope 
intervention, the second group was an informational control group that received and the 
last group was a group that received no information other than regular hospital care. At 
the start of the study, the level of hope was low for all groups compared to other cancer 
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patients (Rustoen, 1998; Herth, 1990, Herth, 2000). A significant difference in the level 
of hope was found in the cancer patients related to level of energy, sleep, and concurrent 
losses. The hope score decreased slightly for all groups at three months. However, the 
hope control group did have significant higher mean hope score than the informational 
group (P=0.034) and the control group (P=0.015). The hope scores also decreased at six 
and nine months for the all groups, but the mean hope score for the hope intervention 
group remained higher than the attention group (P=0.032) and the control group 
(P=0.025) (Herth, 2000). 
Summary of Hope 
Hope is thought to originate from the first stage of psychosocial development 
(Erickson, 1964). The two main spheres of hope are generalized hope and particularized 
hope with six domains: affective, cognitive, behavioral, affiliative, temporal, and 
contextual (Dufault & Martocchio, 1985) Hope occurs during chronic illnesses and 
promotes the healing process (Farran, Herth, & Popovich, 1995). Hope has been studied 
largely in populations with cancer (Dufault & Martocchio, 1985; Rustoen, 1995; Herth, 
1989), in populations with chronic diseases (Duggleby et al., 2010; Lohne & Severinsson, 
2004), and in healthy populations (Farran et al., 1990; Forbes, 1994). Three of the main 
attributes of hope are that it is future orientated, requires energy, and is goal orientated 
(Amendolia, 2010; Dorcy, 2010; Duggleby et al., 2010; Lohne & Severinsson, 2004).  
Health-Related Quality of Life 
The literature search on quality of life surveyed literature from the EBSCOhost 
database (incorporating the following databases CINAHL, MEDLINE, and PsychINFO). 
The search was narrowed to full text and peer-reviewed articles from 2000 to 2017. 
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Articles specifically related to the concept of HRQOL were examined. The literature was 
researched using the terms hope and quality of life together. However, when limiting this 
process further by adding the term Parkinson’s disease, no articles were found. Thus, the 
literature did not address the levels of hope and quality of life in persons with Parkinson’s 
disease.  
Quality of life it is an abstract idea with numerous meanings and with several 
conceptual definitions. Quality of life relates to culture, values, goals, and expectations 
HRQOL specifically relates to physical health and mental health (CDC, 2015). The 
literature discusses HRQOL and Parkinson’s disease in a number of European studies, 
which are reviewed below. 
Winter et al. (2010a, 2010b, 2011) completed a sequence of studies in Europe 
examining HRQOL in Parkinson’s disease. The first study in Austria assessed HRQOL in 
100 persons with Parkinson’s disease and found the HRQOL score was lower than the 
general population (Winter et al., 2010a). Scores related to mobility and pain were high, 
leading to a decrease in HRQOL. Age, depression, motor fluctuations, and disease 
severity were the main determinants of HRQOL. Overall, the Winter et al., (2010a) study 
promoted social support and home care for persons with Parkinson’s disease to improve 
their HRQOL. 
Similarly, a study in Russia investigated the HRQOL in persons with Parkinson’s 
disease. Winter et al. (2010b) noted that Parkinson’s disease affects the vulnerable 
population of the elderly. Their study recognized the importance of assessing HRQOL in 
this population in order to provide better healthcare programs for the more vulnerable. In 
a sample size of 100 persons with Parkinson’s disease, 98% of participants had moderate 
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or severe scores in mobility, pain, and anxiety. The control group had 74%, which is a 
significantly lower HRQOL score in these problem areas (Winter et al., 2010b). 
The last study in the series took place in Italy, where HRQOL in Parkinson’s 
disease showed mobility, pain, and anxiety as common dimensions reducing HRQOL 
(Winter et al., 2011). Other determinants that reduced HRQOL scores were increased 
disease severity, depression, and dementia. The results encouraged the national 
healthcare programs to focus on education and social support in order to improve 
HRQOL related to motor and non-motor symptoms (Winter et al., 2011).  
The prevalence of non-motor symptoms in Parkinson’s disease leads to increased 
disability and is associated with decreased HRQOL (Leonardi et al., 2012; Post et al., 
2011; Weintraub, Moberg, Duda, Katz, & Stern, 2004;). Studies found non-motor 
symptoms associated with decreased HRQOL more than motor symptoms. For example, 
Rodriguez-Violante et al. (2013) identified clinical and demographic factors of HRQOL 
and anticipated decreased HRQOL among patients with advanced Parkinson’s disease. 
The study included 177 patients with Parkinson’s disease in Mexico City. The study 
evaluated patients using several scales, one of which was the Parkinson’s Disease 
Questionnaire (PDQ-39) that measures quality of life of persons with Parkinson’s 
disease. The researchers did not find an association between HRQOL and dyskinesia. 
Specifically, neuropsychiatric features of the disease were more problematic and 
associated with higher scores on the PDQ-39, which is associated with lower levels of 
HRQOL (Rodriguez-Violante et al., 2013).  
Qin et al. (2009) determined the non-motor symptoms of depression, sleep 
disorders, and fatigue attributed to 61.7% of the variance of HRQOL in 391 Chinese 
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patients with Parkinson’s disease. Motor and non-motor symptoms were measured by 
multiple regression analyses to determine which variables were associated with HRQOL. 
The study found that HRQOL improves only if support is provided for all aspects of 
Parkinson’s disease, and not just motor symptoms. 
Miyashita et al. (2011) reported all the domain of quality of life of patients with 
Parkinson’s disease in Japan was significantly lower than in the general population. 
Questionnaires were sent to 1,577 persons with neurological diseases, and of the 785 who 
responded, 273 had Parkinson’s disease. The study explored the correlation between 
quality of life for patients and caregivers. When depression was present in patients, there 
was a significant reduction on quality of life for caregivers. Patients who had decreased 
physical function correlated with an increase in care burden and a decrease in caregiver’s 
quality of life.  
A study in the Netherlands showed that worsening psychosocial well-being, 
mood, and cognitive function over a two-year period was associated with decreased 
HRQOL (Visser et al., 2009). Visser et al. (2009) examined 336 patients longitudinally 
over a two-year period, revealing that patients who have autonomic dysfunctions, 
nighttime sleep problems, and cognitive dysfunction are at risk for deterioration of 
HRQOL.  
Researchers in Scandinavian countries examined quality of life in persons with 
Parkinson’s disease. According to a Swedish study, Parkinson’s disease affects not only 
the quality of life of the individual, but also of the family. Furthermore, the study showed 
that not knowing when to expect impaired mobility leads to frustration and social 
withdrawal in patients (Caap-Ahlgren & Lannerheim, 2002). Parkinson’s disease 
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threatens a person’s ability to maintain family and social contacts, which leads to 
decreased independence (Welsch et al., 2003). Researchers in Denmark explored how 
living with Parkinson’s disease leads to a loss of independence and self-esteem (Haahr, 
Kirkevold, Hall, & Ostergaard, 2011).  
The Global Parkinson’s Disease Survey (2002) examined quality of life in 31 
Parkinson’s disease patients in an outpatient geriatric center in Sweden and reported 
disease severity as a significant predictor for HRQOL. The study showed increasing 
problems as the disease progressed. Even before the disease reached advanced stages, 
quality of life was affected. 
Findley (2002) surveyed people from six countries with Parkinson’s disease and 
discovered depression is significantly associated with quality of life. Findley’s (2002) 
international study of 1,190 patients in six countries associated depression significantly 
with quality of life. Over 50% of patients had a score above 10 on the Beck Depression 
Inventory, indicating mild depression. However, this result was not reflected in the 
patient’s self-assessments, as only one percent of the patients evaluated themselves as 
depressed. 
Gage, Hendricks, Zhang, and Kazis (2003) found that veterans with Parkinson’s 
disease had lower scores on mental and physical health scales compared to veterans with 
other conditions, such as heart disease, congestive heart failure, stroke, diabetes, arthritis, 
or lower back pain. This is a problem because, as the population ages, the number of 
persons with Parkinson’s disease is expected to increase (Welsh et al., 2003), and this 
chronic progressive disease of late adulthood has no cure yet.   
It is important for the healthcare professionals to focus on patients’ perceptions of 
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quality of life and develop strategies for improving daily life for those patients (Wressle, 
Bringer, & Granerus, 2006). In contrast to acute diseases wherein a cure is the ultimate 
goal, the goal of treating Parkinson’s disease is to minimize symptoms and improve 
HRQOL. A study using 1,200 randomly selected participants from the Japanese 
Association of Patients with Parkinson ’s Disease showed that patient education led to 
better HRQOL (Shimbo et al., 2004).  
Winter et al. (2010a, 2010b, 2011) discussed an average of over 80% of patients 
with Parkinson’s disease patients are dependent on cares mostly provided by family 
members. This high number of persons depends on others to help them with their ADLs 
because of their disease severity. Lou (2015) describes as severity of illness increases; 
fatigue severity also increases leading to decreased HRQOL. Fatigue is associated with 
several of the non-motor symptoms of Parkinson’s including apathy, sleep disorders, 
cognitive dysfunction and depression. 
Problems with mobility, anxiety, depression, and pain are common problems 
decreasing HRQOL in persons with Parkinson’s disease (Winter et al., 2011). These 
problems could classify as possible barriers for using this model. Few studies have 
recognized the effect of depression in Parkinson’s disease. However, the impact 
depression has on HRQOL is important to recognize as depression is clearly associated 
with lower HRQOL and health-promoting behaviors (Dowding, Shenton & Salek, 2006; 
Jones, Pohar, & Patten, 2009; Schrag, 2006). Withdrawing from social life is another 
possible barrier that could result in lower HRQOL for persons with Parkinson’s disease.  
Summary of Health-Related Quality of Life 
The conceptual meaning of HRQOL includes the following domains: physical 
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functioning, role physical, bodily pain, general health perceptions, vitality, social 
functioning, role emotional, and mental health (Sigstad et al., 2005). Fourteen studies that 
examined HRQOL in Parkinson’s disease were reviewed. The main determinants of 
HRQOL were age, depression, motor fluctuations, and disease severity (Winter et al., 
2010a). HRQOL is important to assess in persons with Parkinson’s disease because they 
are a vulnerable population (Winter et al., 2010a). This leads to an opportunity to provide 
better healthcare programs for those who are vulnerable.  
Health-Promoting Behaviors  
The literature search on health-promoting behaviors examined literature from the 
EBSCOhost database (incorporating the following databases CINAHL, MEDLINE, and 
PsychINFO). The search was limited to peer reviewed journals published between 2000 
and 2017. Abstracts were reviewed for relevancy to nursing. 
Tengland (2010) defined health promotion beginning as a public health belief and 
emphasizing a holistic model promoting social and economic determinants of health at a 
population level as well as focusing on vulnerable groups and inequality. Trembley and 
Richard (2011) relate health promotion to the individual, group, or community level and 
use a variety of approaches to improve health at an individual and environmental level. 
Glanz and Maddock (2002) describe health-promoting behaviors as the activities 
of multiple levels that correlate with change and policy development as a result of these 
activities. A big outcome of the changes brought about by health-promoting behavior is 
an improvement in coping skills and quality of life.  
Liu et al. (2009) studied women in Taiwan who had an abnormal papanicolaou 
test. This study had a convenience sample of 101 rural women and 14% of these women 
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had precancerous results. In their study, they defined health-promoting behaviors in 
women’s health related to three aspects: health responsibility, stress management, and 
exercise. The researchers developed interventions to help women with positive 
papanicolaou results select treatment options and implement healthy behaviors.  
Pender (1987) developed one of the predominant health-promotion models to 
describe health-promoting behaviors. This model has been published extensively within 
the literature and is commonly used in nursing practice (King, 1994). One strength of the 
health-promotion model is the scale, the Health-Promoting Lifestyle Profile (HPLP), 
which measures self-actualization, health responsibility, exercise, nutrition, interpersonal 
support, and stress management (Walker, Sechrist, & Pender, 1987). The model stresses 
cognitive influences on health, personal decision-making, individual control, and 
individual definition of health (Whitehead, 2001). 
The health-promotion model by Pender works well for preventative, behavioral, 
health-related concepts, and disease-centered concepts (Whitehead, 2001). Stuifbergen 
and Rogers (1997) validated this model when they examined health-promotion behaviors 
related to quality of life for those with chronic conditions.  
Bouchard (1992) used Pender’s framework and studied health-promoting 
behaviors and hope in a population of 76 persons with breast cancer. Bouchard found 
hope correlates significantly with several items from the HPLP questionnaire. Hope has a 
strong relationship with health-promoting behaviors (p=0.001), health responsibility 
(r=.396), stress management (r=.396), interpersonal relations (r=.396), and self-
actualization (r=.624).  
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For the purpose of this research, health-promoting behaviors relate to Pender’s 
(2015) definition relating to increasing health potential and well-being at multiple levels, 
which include individual, family, community, and society. Numerous researchers have 
used Pender’s definition of health-promoting behaviors to help individuals achieve well-
being and improve health.  
Fowler (1997) discussed hope and health-promoting behaviors in persons with 
Parkinson’s disease. The sample consisted of 42 patients with Parkinson’s disease who 
completed the HHI and HPLP II. The study showed a moderate positive relationship 
between hope and a health-promoting lifestyle (r=.40, p=.008). Significant correlations 
related to hope were health-promoting lifestyle, spiritual growth, and interpersonal 
relations. Findings showed women had a higher mean score in physical activity than 
males (t=-2.28, p=0.03). Adults with Parkinson’s disease had a low level of physical 
activity compared to the general population. Even though the population of this study has 
a progressive debilitating disease, they were involved in health-promoting behaviors and 
were considered hopeful. 
Stuifbergen (1995) found similar results in her study with 61 women with 
multiple sclerosis. In this descriptive correlational study, she noted a strong correlation 
between health-promoting behaviors and quality of life. Health-promoting behavior 
subscales of physical activity and nutrition on the HPLP II correlated significantly with 
objective measures of activity and nutrition. Low level of activity in persons with this 
chronic disease may be seen when persons do not over exert due to fatigue, which starts a 
cycle of inactivity resulting in loss of balance, muscle weakness, depression, sleep 
problems, and cardiovascular deficits. Thus promoting physical activity is essential, in 
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not only women with multiple sclerosis, but also the general population.  
Stuifbergen and Roberts (2005) also surveyed health-promoting behaviors and 
quality of life in a convenience sample of 629 women with multiple sclerosis. In this 
sample, women also scored lower on the physical activity and spirituality subscale 
compared to other groups. The method of the study was descriptive correlational and the 
data collection was cross sectional. Health-promoting behaviors in this sample 
contributed to quality of life. Behaviors such as eating healthy, exercise, and stress 
management influence the response to physical deterioration associated with multiple 
sclerosis and other chronic disabling conditions. 
Stuifbergen, Seraphine, Harrison and Adachi (2004) demonstrated that health-
promoting behavior variables are similar in another chronic neurological condition, post-
polio syndrome. This study had a descriptive correlational design and the sample was a 
large convenience sample of 2153 persons with post-polios syndrome. The path 
coefficient in the multiple sclerosis study and the post-polio study were almost equal in 
the samples (multiple sclerosis =0.17 and post-polio=0.19). The relationship implies 
health-promoting behaviors increase quality of life.  
Harrison (1993) examined hope, perceived health status and health-promoting 
lifestyle in persons with HIV. An item of Pender’s scale includes optimism, a dimension 
of health expression, which in this study Harrison identified optimism as hope. Harrison 
found a positive correlation between a health-promoting lifestyle and hope (r=.64, 
p<.001). Hope was entered into a hierarchal multiple regression of accounted for 41.4% 
of the variance. Hope had a strong correlation with self-actualization (r=.78, p<.001), 
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moderately high with interpersonal relationships (r=.78, p.001) and interpersonal support 
(r=.55, p<.001). Hope had a low correlation with stress management (r=.39, p<.001).  
Self-efficacy has been associated with health-promoting behaviors for not only 
persons with chronic disabling conditions, but for all persons (Strecher, DeVellis, Becker, 
Rosenstock, 1986; Stuifbergen & Becker, 1994). Self-efficacy allows persons with 
Parkinson’s disease to be resilient and is essential to cope with chronic illness (Nelson, 
Wong & Lai, 2011). Patients with a variety of chronic conditions were better able to 
manage their symptoms and utilize health care services when they had perceived high 
levels of self-efficacy (Lorig et al., 1999).  
Summary of Health Promotion 
The literature described multiple definitions of health-promoting behaviors in 
persons in a variety of populations including cancer, HIV, and chronic neurological 
conditions such as polio, multiple sclerosis, and Parkinson’s disease. These persons were 
described to have health-promoting behaviors related to their high level of hope 
(Bouchard, 1992; Fowler, 1997; & Harrison, 1993). 
Summary of Gaps in the Literature 
The state of the science shows an association between Parkinson’s disease and 
decreased HRQOL. The literature suggests that HRQOL decreases when non-motor 
symptoms increase disability (Leonardi et al., 2012; Post et al., 2011; Weintraub, 
Moberg, Duda, Katz, & Stern, 2004). The major non-motor symptom associated with 
decreased HRQOL is depression, which is a common factor in Parkinson’s disease 
(Kadastik-Eerme et al., 2002). The literature also established an association between hope 
and quality of life. Herth (2000) noted that quality of life improves in cancer patients who 
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received a hope intervention.  The literature describes hope as an essential component for 
improving quality of life in cancer patients (Rusteon, 1995; Herth, 1990, 2000). This 
connection has not been established in people with Parkinson’s disease.  
Limited research has been completed related to these variables in people with 
Parkinson’s disease. Hope has been studied in healthy persons and persons with chronic 
illness, but not significantly in persons with Parkinson’s disease. Fowler (1997) examined 
the relationship with hope and health-promoting behaviors in persons with Parkinson’s 
disease and found a positive relationship between hope and health-promoting behaviors. 
The presence of all three concepts together is not evident in the literature and only 
Fowler’s article was noted with two of the concepts, thus there is a need for more current 
research, which creates a need for more studies. These three concepts of hope, health-
promoting behaviors, and health-related quality of life have not been studied in persons 
with Parkinson’s disease. This is significant given that the Midwest has the highest 
prevalence of Parkinson’s disease in the world. Expanded knowledge from this study will 
offer understanding into means to improve health-promoting behaviors, hope, and 
HRQOL for those with Parkinson’s disease.  
Theoretical Frameworks 
The conceptual framework for this study is based on Stuifbergen & Roger’s 
(1997) Explanatory Model for Health-Promotion within Chronic Conditions. The model 
is well tested and incorporates concepts from Pender’s (1987) Health-Promotion Model 
(HPM) and Bandura’s Social Cognitive Theory (1986). The concepts from Pender and 
Bandura are the backbone for Stuifbergen’s theory.  
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Development of Explanatory Model of Health-Promoting Behaviors within Chronic 
Conditions 
Pender’s Health Promotion Model. Stuifbergen’s Explanatory Model of Health-
Promoting Behaviors within Chronic Conditions is based on the HPM, a theoretical 
framework describing relationships that contribute to a health-promoting lifestyle. 
Initially Pender (1987) developed the HPM as a framework that serves as a guide for 
predicting behaviors. The HPM is helpful in investigating different factors that influence 
a person’s ability to perform health-promoting behaviors. Behaviors include self-
actualization, health responsibility, physical activity, nutrition, spirituality, interpersonal 
support, and stress management (Pender, 1996). 
Marriner- Tomey & Alligood (2010) describe the concepts of Pender’s HPM as 
follows: Behaviors that relate to prior behavior have an influence on current health-
promoting behaviors. Personal factors such as biological, psychological, and 
sociocultural factors also influence current health-promoting behaviors. The perceived 
benefits of action equal the benefits of getting on board with the health activities. 
Perceived barrier are problems like lack of money, which could delay health-promotion 
activities. Perceived self-efficacy is a strength to persevere and meet goals attributing to 
health promoting behaviors. Activity related affect is an interchange of activities not 
related to health-promotion activities. Interpersonal influences include different 
relationships that Situational influences prepare the individual for or steer them away 
from participating in health-promoting activities. Commitment to a plan of action 
summarizes steps to take health promotion tactics. Immediate competing demands and 
preferences include any part of the individual’s life that interferes with accomplishing 
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health-promoting behaviors. Anything that causes a favorable health outcome is 
considered a health-promoting behavior (Marriner-Tomey & Alligood, p. 438-439. 
2010). 
Social Cognitive Theory (SCT). Self-efficacy undergirds Stuifbergen’s model 
and was first introduced as a major assumption of Bandura’s SCT. Bandura (1997) 
describes self-efficacy to be a person’s belief about their abilities to control their own 
behavior and events affecting their lives. Self-efficacy plays a role in decreasing stress 
and improving coping through a person’s self-appraisal of coping abilities necessary to 
deal with a stressful event (Bandura, 1989; Benight & Bandura, 2004). Self-efficacy is 
needed to maintain social and coping skills required for chronic disease management.   
Explanatory Model of Health Promotion and Quality of Life in Chronic Disabling 
Conditions 
The Explanatory Model of Health-Promotion and Quality of Life in Chronic 
Disabling Conditions developed by Stuifbergen & Rogers (1997) has been validated 
twice, first in persons with multiple sclerosis and second in persons with post-polio 
syndrome (Stuifbergen, Seraphine & Roberts, 2000; Stuifbergen, Seraphine, Harrison, & 
Adachi, 2004). This model describes how disease severity has an effect on health-
promoting behaviors and quality of life. Therefore, Stuifbergen’s Model of Health-
Promotion and Quality of Life in Chronic Disabling Conditions is a good fit for this study 
on health-promoting behaviors, hope, and HRQOL in persons with Parkinson’s disease. 
According to Stuifbergen and Roger’s (1997) health promotion model, strategies 
need to be priority for serving persons with chronic disabling conditions. The authors 
describe health promotion fitting together with rehabilitation with a common goal of 
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improving quality of life. In order for persons with chronic disabling conditions to 
function at their full potential, they must engage in health-promoting behaviors. 
Stuifbergen, Harrison, Becker and Carter (2004) verified health-promoting 
behaviors decrease the influence of disease severity on QOL. Their research recommends 
supporting health-promoting behaviors and self-efficacy to maintain and improve QOL. 
Combining health-promotion and self-efficacy is a powerful strategy for working with 
persons with chronic disease. The combination may lead to an improvement in health 
when persons meet health goals despite disease progression. Empowering persons with 
chronic diseases to use health-promoting behaviors is congruent with Pender’s (2015) 
belief that health happens alongside the illness experience. Despite the limitations caused 
by Parkinson’s disease in motor function or non-motor functions, the person still strives 
for good health.  
The explanatory model describes how the concepts of perceived barriers, 
resources, and self-efficacy effect health-promoting behaviors (Meraviglia, Stuifbergen, 
Parsons, & Morgan, 2013). The model discusses how severity of illness could impair 
quality of life, but is remedied some by the mediating variables of health-promoting 
behaviors and the antecedent variables of barriers, self-efficacy, resources, and 
acceptance (Stuifbergen et al., 2004, p. 384).  
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Figure 2. Explanatory model of health promotion and quality of life in chronic disabling conditions 
(Stuifbergen & Rogers, 1997) used with permission from author. 
Stuifbergen et al. (2004) describe the Explanatory Model of Health Promotion and 
Quality of Life for Persons with Chronic Illnesses as follows: severity of illness impairs 
quality of life, but is reduced by health-promoting behaviors and the antecedent variables 
of barriers, self-efficacy, resources, and acceptance (p. 384). Severity of illness for 
Parkinson’s disease patients increases as the disease reaches advanced stages.  Health-
promoting behaviors include physical activity, nutrition, and stress management 
(Stuifbergen et al., 2005). Barriers include problems with motor function, cognitive 
function, and pain leading to decreased HRQOL. Self-efficacy improves health-promoting 
behaviors and is a strength to persevere and meet goals (Marriner-Tomey & Alligood, 
2010). Resources could link to finances, social support, and hope. Acceptance improves 
coping skills and thus improved quality of life. The concepts of the model are described 
in further detail below.  
Severity of Illness. When severity of illness increases, barriers are expected to 
increase (Stuifbergen & Rogers, 1997). Severity of illness for Parkinson’s disease 
patients would affect their activities of daily living, being ability to dress or bathe 
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themselves. Winter et al. (2010a, 2010b, 2011) discussed an average over 80% of patients 
with Parkinson’s disease patients are dependent on cares mostly provided by family 
members. This high number of persons depend on others to help them with their ADLs 
because of their disease severity. Lou (2015) describes as severity of illness increases; 
fatigue severity also increases leading to decreased HRQOL. Fatigue is associated with 
several of the non-motor symptoms of Parkinson’s including apathy, sleep disorders, 
cognitive dysfunction and depression.  
Barriers. Problems with mobility, anxiety, depression, and pain are common 
problems decreasing HRQOL in persons with Parkinson’s disease (Winter, 2011). These 
problems could classify as possible barriers using this model. Few studies have 
recognized the effect of depression in Parkinson’s disease. The impact depression has on 
HRQOL is important to identify as depression is clearly associated with lower HRQOL 
and health-promoting behaviors (Dowding, Shenton & Salek, 2006; Jones, Pohar, & 
Patten, 2009; Schrag, 2006). Withdrawing from social life is another possible barrier that 
could result in lower HRQOL for persons with Parkinson’s disease. 
Self-efficacy. Research has indicated self-efficacy improves health-promoting 
behaviors for not only persons with chronic disabling conditions, but for all persons 
(Strecher et al., 1986; Stuifbergen & Becker, 1994). Self-efficacy allows persons with 
Parkinson’s disease to be resilient and is essential to cope with chronic illness (Nelson, 
Wong & Lai, 2011). Patients with a variety of chronic conditions were better able to 
manage their symptoms and utilize health care services when they had perceived high 
levels of self-efficacy (Lorig et al., 1999).  
Resources. Key resources noted in Stuifbergen’s explanatory model are social 
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support and income. In Stuifbergen’s study of persons with MS, emotional support was 
linked to health-promoting behaviors (Stuifbergen, 1995). For persons with Parkinson’s 
disease key resources could also link to social support. Social support was studied related 
to coping and quality of life in Parkinson’s disease and found symptoms of Parkinson’s 
disease are correlated with social implications (Schreurs, De Ridder, & Bensing, 2000) 
For example, some of the symptoms of Parkinson’s disease such as tremors, motor 
problems and apathy can lead to social isolation. Income is also a relevant resource for 
persons with Parkinson’s disease because of high medical treatment costs. Typically, 
private insurance will not pay for approval of medical treatment such as deep brain 
stimulation (DBS). This expensive treatment works by implanting an electrode in the 
brain to inhibit abnormal nerve signals and is sometimes referred to as a brain pacemaker. 
This technique decreases tremors and improves abilities for persons to complete ADLs. 
Patients who have had DBS report significant improvement in symptoms and higher 
quality of life (Perestelo-Pérez et al., 2014).  
Acceptance. The final approach used by persons with a range of chronic 
disabling conditions to foster health-promoting behaviors is acceptance (McWilliam, 
Stewart, Brown, Desai, & Coderre, 1996). The acceptance phase discusses how the 
disease fits into the person’s lifestyle and does not equal giving up (Stuifbergen, 
Seraphine, Harrison & Adachi, 2005). In persons with Parkinson’s disease acceptance 
helps the patient cope, which in turn coping leads to significantly improved HRQOL 
related to cognitive impairment, communication, and discomfort. Clinical interventions 
program such as acceptance and group mindfulness programs may benefit HRQOL in 
persons with Parkinson’s disease (Bucks et al., 2011). 
40 
 
Conclusion 
The literature supports the occupational risks of farming and pesticides associated 
with Parkinson’s disease (Kenborg et al., 2012; Kamel et al., 2007; Wright Willis et al., 
2010). The increasing incidence of Parkinson’s disease as the population ages is 
concerning for those at greater risk in farming communities in America. Parkinson’s 
disease is associated with decreased HRQOL and studies show an increase in the Hoehn 
and Yahr stage of disease severity correlates with even worse quality of life (Goetz et al., 
2004). On the contrary, the concept of hope is associated with an improvement in quality 
of life. Hope has been studied in a variety of populations including healthy populations, 
those with chronic diseases, and cancer (Dufault & Martocchio, 1985; Farran, et al., 
1990; Forbes, 1994; Duggleby et al., 2010; Herth, 1989; Rustoen, 1995). Hope improves 
when a person received a hope intervention in persons with cancer, but no research has 
established this connection in people with Parkinson’s disease.  
HRQOL has been assessed in multiple populations including persons with 
Parkinson’s disease (Sigstad et al., 2005; Leonardi et al., 2012; Miyashita et al., 2011; 
Post et al., 2011; Rodriguez- Violante et al., 2013; Visser et al., 2009;Weintraub, 
Moberg, Duda, Katz, & Stern, 2004; Welsch et al., 2003; Winter et al., 2010a, 2010b, 
2011). An association of health-promoting behaviors and a strong HRQOL have been 
established in the literature (Stuifbergen, 1995; Stuifbergen & Rogers, 2005; Stuifbergen, 
et al., 2005). However, this specific association of health-promoting behaviors, HRQOL, 
and hope has not been established for people with Parkinson’s disease which could have 
a significant impact given the high incidence of Parkinson’s disease in the Midwest.  
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The theoretical model by Stuifbergen et al. (2004) is a good fit for this study 
because it describes quality of life for persons with chronic illnesses. The model has been 
validated twice, once in persons with polio and once in persons with multiple sclerosis. 
The health promoting behaviors measured in the model by Stuifbergen include physical 
activity, nutrition, and stress management. Other health-promoting behaviors not 
included in the model, but which will be measured in this study include health 
responsibility, spiritual growth, and interpersonal relationships. See Health Promoting 
Lifestyle Profile II Instrument (see Appendix C).   
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CHAPTER 3: RESEARCH METHODOLOGY 
Introduction 
This chapter examines the research design used to organize the study. Plans for 
sampling, instruments, data collection, and the data analysis in a systematic fashion are 
described. The protection of human subjects and ethical considerations are reviewed. 
Research Design 
A descriptive correlational design was used to examine the relationships among 
health-promoting behaviors, hope, and HRQOL in persons with Parkinson’s disease. 
Descriptive research paints a picture of characteristics and situations as they happen 
naturally in a single sample (Burns & Grove, 2011). A descriptive correlational design is 
appropriate as this study examines the relationship among the variables of health-
promoting behaviors, hope, and quality of life portrays an image of life as it happens for 
persons with Parkinson’s disease. According to Portney and Watkins (2009), a 
correlational design describes relationships among variables and is exploratory in nature. 
No attempt is made to control or manipulate the variables. Burns and Grove (2011) assert 
that correlational descriptive studies review circumstances in the past or in the present 
and can quickly identify many interrelationships in that situation. This type of design is 
also helpful to develop hypotheses for future studies. The role of a covariate in statistical 
data is to show the correlation among variables, directly or indirectly, without trying to 
establish a causal relationship  
Sample 
According to Portney and Watkins (2009), the appropriate study sample size is 
important determining the power of the test. If the sample is small, then the data is not 
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likely an accurate portrayal of the population and increases the chance of an error. This 
type of error happens when the researcher accepts the data as true when it is false. This is 
a type II error, meaning that the researcher failed to discover the presence of the effect, 
which is a false negative. Having a smaller sample size is also harmful because it 
decreases the power of the test. Conversely, statistical power increases with a larger 
sample. Power links directly to the sample size and is a critical ability of a test to find if 
an effect truly exists (Field, 2014). A sample size of 176 was projected, using a power 
analysis based on an alpha of 0.05, power of 0.80 and Cohen’s convention for a medium 
effect (r = 0.30) (Polit & Beck, 2012) and a sample size of 179 was attained.  
Participants were persons with Parkinson’s disease attending support groups in 
the Midwest and attendees of the South Dakota 2016 Annual Parkinson’s Awareness 
Conference. Participants were also from the Midwest Parkinson’s Foundation mailing 
list. A convenience sample of persons with Parkinson’s disease who met inclusion 
criteria for participation were included. This yielded a sample size of 179, which was 
over the minimum sample size of 176 participants. The exclusion criteria included 
persons with severe dementia or dysphasia, which impaired their ability to communicate.  
The inclusion criteria for the study included English-speaking adults with 
Parkinson’s disease. The population gave consent to participate by returning their survey. 
The study population included both males and females. Participants in nursing homes and 
assisted livings were also included in this study. Marital status was not an inclusion or 
exclusion criteria.  
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Setting 
The study utilized Parkinson’s disease support groups located in a Midwestern 
state. Initially data were collected from three cities in a Midwestern state. One of the 
major cities, which is on the southeast side of the state, has a population of 168,586 (city-
data.com, 2014). This community is the fastest growing metro area in this state 
(Businessweek, 2011). Over 80% of the population is Caucasian and 90.7% of the 
population has high school education (U.S. Census Bureau, 2014). The median age is 
34.2 years (city-data.com, 2014). Another major support group is located in a city with a 
population of 23,225 and is on the eastern side of the state (city-data.com, 2014). The 
median resident’s age is 22.7 years, which is perhaps lower because of a university 
located in the city. The third major city in this study has a population 22,057, which is 
also on the eastern side of the state. The median age is 36.4 years (city-data.com, 2014). 
All three cities have similar ethnicity and education percentages (U.S. Census Bureau, 
2014).  
Three additional support groups in different cities were added to the study to 
reach the sample size. A support group was added in a city on the western side of the 
state. This city has a population of 73,569 and 80% of the city is Caucasian. The high 
school graduation rate in this city is 91.7%. The second additional support group was in 
the southeastern part of the state. The city has a population of 22,702, and 92.5% of the 
population is Caucasian. Like the other cities, the high school graduation rate is greater 
than 90% (U.S. Census Bureau, 2015). The final city was in the eastern part of the state 
and had a population similar in size to two of the other cities with a population of 22,574; 
however, the high school graduation rate of this city was lower at 74.1% (U.S. Census 
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Bureau, 2015). Several surrounding communities came to this support group and this 
group had the highest attendance with 28 persons with Parkinson’s disease.  
Support groups in these cities met monthly and offer support for persons with 
Parkinson’s disease, their caregivers, and friends. Support groups also provided 
education, socialization, opportunities to share worries or discuss new information on 
Parkinson’s disease treatment. Support groups are free and open to anyone in the 
community (Parkinson’s Association of South Dakota, 2016).  
Instruments 
Participants completed four instruments. First, a demographic instrument 
collecting data on background information was used to describe the sample. Next, the 
Health Promoting Lifestyle Profile II (HPLP II), the Herth Hope Index (HHI) and the 
Parkinson’s disease questionnaire-8 item version (PDQ-8), which measures HRQOL in 
Parkinson’s disease patients were administered. Additionally, disease severity was 
assessed for each person based on the Hoehn and Yahr scale. 
Demographic Instrument for Background Information. A demographic 
instrument for collecting background was developed for the study (see Appendix A). 
Basic demographic variables include age, gender, marital status, ethnicity, religious 
affiliation, and length of time since diagnosis. Munro (2005) describes nominal data as 
the lowest form of measurement because it limits the ability to control and perform 
statistical tests on the data. 
Hoehn and Yahr Scale. Disease severity was assessed based on the Hoehn and 
Yahr scale (see Appendix B). Hoehn and Yahr (1967) developed a scale for practitioners 
to stage Parkinson’s disease that is still commonly used today. The scale includes the 
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following five stages:  
1.  Unilateral or one-sided involvement. 
2.  Bilateral, which involves both sides and mild disease. 
3.  Bilateral disease with worsening balance and mild to moderate disease. 
4.  Severe disease, which requires extensive assistance. 
5.  Confinement to bed or wheelchair unless assisted and possible tracheostomy or  
      feeding tube.  
According to Bunting-Perry and Vernon (2007), the scale is not related to 
prognostic factor as the progression of the disease is so variable for patients, but rather a 
simple snapshot describing the persons’ current rating of disease. Medication timing and 
dosing can change the outcome of the rating scale. Goetz et al., (2004) notes a lack of 
formal psychometric properties such as reliability and validity of the Hoehn and Yahr 
scale. The scale combines assessing disability and impairment.  Because the scale is an 
ordinal scale, reliability testing is limited. The scale stage was self-reported by persons 
with Parkinson’s disease. Overall, the scale has widespread use and is accepted by those 
in practice. In research, the scale is useful primarily in determining inclusion/exclusion 
criteria.  
Health Promoting Lifestyle Profile II Instrument Review. The instrument 
chosen to measure health-promotion in this study was the Health Promoting Lifestyle 
Profile (HLPL) II instrument (Walker, Sechrist, & Pender, 1995) (see Appendix C). The 
psychometric properties of the scale include a strong internal consistency, Cronbach’s 
alpha of .94 and with a test-retest reliability of .89 (Pender, 2011). The scale has 52 items 
with a 4-point scale assessing how often participants engage in health-promoting 
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behaviors. Six dimensions on the scale include health responsibility, nutrition, physical 
activity, spiritual growth, interpersonal relationships, and stress management. A factor 
analysis confirmed a six-dimensional structure of health-promoting behaviors. Content 
validity was obtained by literature review and the content experts’ evaluation (Walker & 
Hill-Polerecky, 1996). Each of the dimensions is scored separately as a specific subscale 
and then together for a total score. Scores range from 1 (never) to 4 (routinely) and higher 
scores equal greater health-promoting behaviors. The scale takes an estimated 10 minutes 
to complete. Permission to use this tool was obtained from the author (N. Pender, 
personal communication, March 28, 2016). 
Hope Scale Instrument Review. This study used the Herth Hope Index (HHI) to 
measure hope (see Appendix D). The HHI is a 12-item instrument for assessing hope in 
adults and was developed from the 30-item Herth Hope Scale (HHS). It is used to assess 
change related to how much an individual agrees with the statement at the moment of 
completing the instrument. The items are rated on a Likert scale from 1 (strongly 
disagree) to 4 (strongly agree) (Herth, 1992). The original hope scale items were created 
to reflect Dufault and Martocchio’s (1985) concept of hope, which is the conceptual 
definition used in this study.  
The HHI was validated through factor analysis and internal consistency in a 
convenience sample of 172 ill adults and has a Cronbach’s alpha= 0.78-0.97 (Herth, 
1992; 1993). Test-retest reliability of 0.91 also indicates high stability of this scale 
(Bluvol & Ford-Gilboe, 2004). The possible range of scores, once added together, range 
from 12 to 48 (Herth, 1992). The initial Cronbach’s alpha was 0.94. The HHI pilot did 
not show a ceiling or floor effect in the item mean effect of the instrument (Herth, 1992). 
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Permission to use this tool was obtained from the author (K. Herth, personal 
communication March 16, 2013).  
Health-Related Quality of Life Instrument Review. This study used the PDQ-8 
to measure HRQOL (see Appendix E). The PDQ-8 is widely validated and represents a 
good instrument to measure HRQOL. The scale is also responsive to treatment effects 
and is easily administered (Fereshtehnejad et al., 2014). The construct validity was based 
on an exploratory factor analysis on evidence from eight measures representing the 
subscales that have established reliability, internal consistency Cronbach’s alpha greater 
than 0.7, and test-retest reliability was established. In the PDQ-8, the lower scores predict 
higher HRQOL.  
Multiple scales have been created to assess HRQOL in Parkinson’s disease. The 
gold standard scale used most frequently to measure HRQOL in Parkinson’s disease is 
the PDQ-39, which is the parent tool for the PDQ-8. The PDQ-8 has similar properties to 
the parent tool and was chosen instead of the PDQ-39 because of ease of administration 
and to prevent participant burden due to the large number of tools being used in this 
study.  
The domains of the PDQ-8 represent a dimension from each of the following 
areas on the PDQ-39: “mobility, activities of daily living, emotional well-being, stigma, 
social support, cognition, communication and bodily discomfort,” (Rodriguez-Violante et 
al., 2013, p.11). The tool is free for use for scientific purposes and requires less than 10 
minutes to administer. The shorter tool has a single index figure and a smaller number of 
items. It has less participant burden and requires less time to administer than the 20 
minutes of the PDQ-39.  
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The PDQ-8 has been validated in several countries including the USA, Canada, 
UK, Singapore, Greece, Italy, Spain, Persia, China, and Japan (Jenkinson & Fitzpatrick, 
2007; Jenkinson, Fitzpatrick, Peto, Greenhall, & Hyman. 1997; Tan, Luo, Nazri, Li, & 
Thumboo, 2004). Permission was obtained from the author to use the instrument (C. 
Jenkinson, personal communication, March 8, 2013).  
Data Collection 
Human Subject’s Protection. Permission was obtained from the SDSU Human 
Subject committee. Participants were told the purpose of the study, the risks and benefits 
of the study, and nature of their contribution to the study. The participants were 
guaranteed confidentiality. A letter of consent was given to each participant and return of 
the surveys is considered their consent for participation. Confidentiality was upheld and 
all names of participants, addresses or any identifiers were removed.  
Subject Recruitment. The participants were recruited from support groups in a 
Midwestern state. Average attendance at support group meeting is 20-40 persons. Each 
group meets at a set time on a monthly basis in either the afternoon or evening. 
Participants were also recruited at the South Dakota Annual Parkinson’s Awareness 
Conference by a sign-up sheet for surveys to be mailed. The conference has an average 
attendance of 100 persons. The number of participants from the projected three support 
groups and conference did not meet the goal of the study; therefore, six additional 
support groups were visited to obtain an adequate sample size. 
Data Collection Process. At nine different support groups, persons were invited 
to join the study. Prior to the meetings, support group leaders were contacted by email or 
phone for permission to administer the survey at the meetings. A presentation was given 
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at the support group meetings on nutrition at several of the meetings. The survey 
instruments were given to those at the support group meetings and a large manila 
envelope was placed in the back of the room for participants to return their survey once 
completed.  
The other surveys were mailed to those not in attendance at the support groups 
with a return self-addressed stamp envelope (Appendix G). Dillman et al. (2014) was 
used as a guideline for the data collection process for these surveys. Dillman describes 
the importance of personalization and following up with participants using a five-contact 
method during implementation to ensure high response rates. The first step was to 
distribute letters explaining the study. These participants were mailed a reminder to 
complete the survey and then finally a thank you letter was mailed once the survey was 
completed and returned (see Appendix H).  
Persons were also informed about the study at the South Dakota Annual 
Parkinson’s Awareness Conference, where persons with Parkinson’s disease were asked 
to sign up if they were interested in participating in the study. These participants were 
mailed a survey and received reminders to complete and return the survey. A thank you 
letter was mailed to them once the survey is complete.  
Analysis 
Statistical analyses were conducted using IBM Statistical Package for the Social 
Sciences (SPSS 21.0). Statistical tests were used to measure the relationships between 
hope, health promoting factors, and health-related quality of life. The data from the 
survey responses were typed by hand and entries were double-checked by researcher after 
numbers were imported into SPSS. 
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Pearson’s correlation coefficient was used to measure the strength of the 
relationship between the variables to quantify the relationship between hope, health-
promoting factors and HRQOL. A significance level or alpha level of p < 0.05 was used 
and a one tailed t- test was used to test if Pearson’s correlations were significant. The 
following hypotheses were tested: 1) There is a positive relationship between hope and 
health-promoting behaviors, and 2) There is a positive relationship between health 
promoting-behaviors and hope on HRQOL. 3) Hope and health-promoting behaviors may 
predict HRQOL modifying for disease severity. The variables of hope, health-promoting 
behaviors, and HRQOL were measured in multiple regressions and a path analysis. 
According to Munro (2005), multiple regressions are used to predict outcomes. In this 
study, multiple regressions were used to identify statistical significant predictors of 
health-promoting factors and HRQOL. Multiple regressions tested the variances 
recognized as enablers and obstacles for hope and health-promoting behaviors. 
A path analysis tests for the relationship between independent and dependent 
variables (Murnro, 2005). In this study, a path analysis determined the relationship 
between the independent or antecedent variables of hope, health-promoting behaviors and 
the dependent- outcome variables of HRQOL. Direct and indirect effects of confounding 
variables were evaluated. 
Demographic data was analyzed using frequency numbers and percentages from 
participants. The background information sheet for demographics was collected. 
Relationships were reported between the background demographic data to hope and 
health-promoting behaviors using correlational matrixes. A t-test was used for exploring 
differences between the means (Polit & Beck, 2012) of the demographic variables. 
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variables will be studied by using non-parametric tests if the group size is not equal 
(Field, 2014).  
Missing Values 
Missing values were assessed if they were occurring randomly or non-random. 
Less than five percent of a total missing values is considered ignorable and no pattern 
occurred (Hair et al., 2010). These authors also recommend deleting variables that are 
missing15 percent of data. The Most Completely at Random (MCAR) test assessed if 
data were missing independently and no cases were identified as problematic in this 
sample. Assessing the missing data found no patterns were and 0.27% values were 
missing for overall data. 
For this research, an imputation technique was used to replace missing data with 
the mean. According to Munro (2005), one process of imputation uses the mean 
replacement because this procedure does not change the distribution and is a conservative 
way to validate missing numbers to provide a complete data set. 
Threats to Reliability and Validity 
Burns and Grove (2011) describe three ways to provide protection against threats 
to validity in a descriptive design study. First links need to be present for conceptual and 
operational definitions of variables. In this study, the conceptual definition of hope by 
Dufaut and Martocchio (1985) was operationalized in the questions of the HHI tool. The 
other definitions and tools are connected. The second way to protect against bias relates 
to sample selection and size.  
The sample selection and size may be skewed compared to the general population 
of patients with Parkinson’s disease because the sample is selected in the Parkinson’s 
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disease belt where patients have higher prevalence and incidence of the disease. In 
addition, the sample may have more ethnically similar individuals who are genetically 
susceptible to Parkinson’s disease residing in this geographic area of the study.  The final 
way to protect from bias is to use valid and reliable instruments for data collection 
procedures. This study’s instruments have solid validity and reliability.  
Summary 
This study examines the relationship of health-promoting behaviors, hope, and 
HRQOL for persons with Parkinson’s disease. Additionally, hope and health promoting 
behaviors may help ease the burden of the disease and possibly lead to a positive effect 
on quality of life. The study methods, procedures, and instruments are reviewed.  
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CHAPTER 4: RESULTS AND ANALYSIS  
Introduction 
This chapter presents the results of the research and describes the demographics 
of the sample, variable testing, and results of test validity and reliability. The data were 
collected in surveys and responses entered by hand into an Excel spreadsheet and double-
checked by researcher. Then the data were imported into the IBM Statistical Package for 
the Social Sciences (SPSS) version 22 for statistical analysis. The purpose of this study 
was to determine the relationship between hope, health-promoting behaviors, and 
HRQOL in persons with Parkinson’s disease. A statistician was consulted for the review 
of results and analysis.  
This study was designed to answer specific research questions. The results from 
the first research question analyzed the level of hope in persons with Parkinson’s disease. 
The findings from the second question described the relationship between hope and 
health-promoting behaviors on HRQOL in persons with Parkinson’s disease. The results 
from the final question examined the relationship among hope, health-promoting 
behaviors, and HRQOL, while controlling for disease severity. 
Sample Characteristics 
A convenience sample was selected of participants from Parkinson’s disease 
support groups and the South Dakota Parkinson’s Awareness Conference. The survey 
was completed by persons with Parkinson’s disease at nine support groups in a Midwest 
state between July and December 2016. The groups ranged from seven to 34 attendees 
per meeting. One person attending the support group had another neurologic disease 
other than Parkinson’s disease, and that survey was excluded. Eight surveys were 
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excluded due to incomplete survey tools. There were 149 surveys returned from support 
groups and South Dakota Parkinson’s Awareness Conference, which accounted for 83% 
of the total participants. 
Additional participants from a mailing list from the Midwest Parkinson’s 
Foundation received a pre-notice letter (n=100) introducing the study. Those participants 
received the survey by mail and 30 returned the survey, a return rate of 30%. The 30 
mailed surveys account for 17% of the total sample. Their primary care provider or a 
neurologist had told all participants they had Parkinson’s disease.  
Results and Analysis 
Setting. The persons in the support groups and at the conference were handed the 
pre-notice letter to participate in the study. Next, they were given the cover letter, which 
stated informed consent if the survey was returned. Lastly, they were given the packet of 
surveys with the Herth Hope Index, HPLP-II, PDQ-8 questionnaires, and a self-addressed 
stamped return envelope.  
           Participants from the mailing list were mailed the pre-notice letter to participate in 
the study.  Then they were mailed the cover letter, which stated informed consent if the 
survey was returned. Finally, the packet of surveys with the Herth Hope Index, HPLP-II, 
PDQ-8 questionnaires, and a self-addressed stamped return envelope was mailed. 
Participants were requested to return the questionnaires in the self-addressed stamped 
return envelope. These participants were also mailed a letter two weeks after the survey 
was mailed, thanking them if they had already completed the survey and reminding them 
to complete the survey if they had not already done so. Total surveys were distributed to 
250 persons.  
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Demographic Data. The demographic variables collected were age, gender, 
marital status, ethnicity, time (in years) since the diagnosis, and whether the participant 
grew up on a farm.  The antecedent variables or independent variables were hope, health-
promoting behaviors, and disease severity. The outcome variable or dependent variable 
was HRQOL. Descriptive statistics were performed on demographic characteristics. 
Demographic Results. Persons with Parkinson’s disease (N =179) completed the 
survey. Persons with Parkinson’s disease who completed the survey were almost 
exclusively Caucasian. Participants were predominantly male, 60.9%. The age ranged 
from 37 to 96, and the majority of participants were between 66 and 75. Most participants 
surveyed had been diagnosed between one to five years prior. Fewer than half of the 
participants, 45.3%, had grown up on a farm or in a rural area.  
Age. Fifty-three percent were diagnosed with Parkinson’s disease between one to 
five years prior. The mean age of the study sample participant was 73 years. The median 
age of the study participants was 74 (see Table 1). The mean age for persons in the 
United States with Parkinson’s disease is unknown. According to the Parkinson’s Disease 
Foundation, the national average of diagnosis is 60 years. The participants in this study 
were generally diagnosed with Parkinson’s disease later in life than the national average 
age of diagnosis of 60 years (PDF, 2016). 
  
57 
 
 
Table 1 
 
Age of Study Participants_______ ______  
Age Participants Percent 
<55 7 3.9 
56–60 6 3.3 
61–65 19 10.6 
66–70 37 20.7 
71–75 41 22.9 
76–80 28 15.6 
81–85 28 15.6 
>85 13 7.4____ 
 
Gender. According to national data from the Parkinson’s Disease Foundation 
(2016), males are 1.5 times more likely to have Parkinson’s disease than females. 
Participants in this study were 60.9% male and 39.1% female. This study aligned with the 
Parkinson’s Disease Foundation data, with 1.6 times more males than females (see Table 
2). 
 
Table 2 
 
Gender of Study Participants__________________ 
Gender Participants Percent 
Male 109 60.9 
Female 70 39.1___ 
 
 
Ethnicity. Study participants were 98.3% Caucasian, 1.1% Hispanic, and 0.6% 
Japanese (see Table 3). To date, very few studies have collected data on ethnicity. 
Research is not conclusive if disease varies by ethnicity. Most studies reviewed included 
Caucasian. Some studies noted by Kaiser Permanente Research (1994–1995) showed that 
African Americas and Asians were at less risk to develop Parkinson’s disease; however, 
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Parkinson’s disease affects people from all ethnicities and backgrounds, regardless of 
social economic status or geography (Van Den Eden et al., 2003). 
Table 3 
 
Ethnicity of Study Participants_________________ 
Ethnicity Participants Percent 
White/Caucasian 176 98.3 
Hispanic 2 1.1 
Japanese 1 0.6____ 
 
Relationship Status. The majority of participants, 78.2%, were married, and 
11.7% were widowed. The remaining 11.1% were divorced, single, separated, or in 
relationships but not married (see Table 4). 
Table 4 
 
Marital Status of Study Participants_______________ 
Marital Status Participants Percent 
Divorced 9 5.0 
In relationship, not married 2 1.1 
Married 140 78.2 
Separated 1 0.6 
Single, never married 6 3.4 
Widowed 21 11.7___ 
 
Length of Time Since Diagnosis. The mean number of years since diagnosis was 
7.11 years. The median number of years was five years. The majority (82%) of the 
persons in the support groups were diagnosed within the last 10 years, 53% were 
diagnosed between one and five years and 29% between six and 10 years (see Table 5).  
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Table 5 
 
Number of Years since Diagnosis________________ 
Diagnosis in years      Participants_________Percent_ 
1-5 95  53% 
6-10  51 29% 
11-15 15 8% 
16-20 9 5% 
>20 9 5%____ 
 
Time on Farm. Over half of the participants did not have a farming background. 
Eighty-one participants, or 45.3% of the sample, grew up on a farm (see Table 6).  
Previous research found pesticides from agriculture increases the risk for Parkinson’s 
disease (Gatto et al., 2009; Marder et al., 1998; Morano et al., 1994; Smargiassi et al., 
1998; Wang et al., 1993; Wechsler et al., 1991; Wong et al., 1991). Possibly, the number 
of persons in attendance at the support group was lower for those associated with 
agriculture because it was during harvest.  
Table 6 
Participants Who Grew Up on a Farm____________ 
Farming background Participants Percent_ 
Yes 81 45.3 
No 97 54.2___ 
 
            Analysis of Demographics. Demographic comparison to statistics for persons 
with Parkinson’s disease was challenging because the United States is lacking a current 
accurate reporting system. The scarcity of data on the incidence of Parkinson’s disease is 
likely to improve because on December 13, 2016, President Obama signed the Cures Act 
into law. This will allow the Centers for Disease Control and Prevention (CDC) to collect 
demographics on sex, age, ethnicity, and geographic distributions of Parkinson’s disease 
and other neurologic diseases in the US. The new reporting system, National 
Neurological Conditions Surveillance System at the CDC, will help increase 
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understanding of demographics and strengthen future research when implemented (Falce, 
2016). 
            Summary of Demographic Data Analysis. Demographic standards for 
comparison were difficult to attain due to lack of national reporting system. The data 
collected by the PDF shows that for the support groups in this study the baseline for 
diagnosis is at a higher age than the national average of diagnosis of 60. This may be 
related to lack of providers that are specialists in the state for neuromuscular disorders, or 
there may be a delay in seeking treatment with early signs of Parkinson’s disease. 
Education on signs and symptoms for persons to report to a doctor and better screening 
by providers is needed to improve diagnosis. Delayed onset of disease could also be a 
possibility. The study’s data on gender for men being more likely than women was 
almost identical. The ethnicity was predominantly Caucasian at 98%. This aligns with 
data from the Parkinson’s disease foundation and from a study by Kaiser Permanente that 
found that the majority of the incidence for Parkinson’s disease is Caucasian (13.5 per 
100,000) (PDF. 2016; Van Den Eeden et al., 2003). 
 The length of time since diagnosis correlated with a high number of persons who 
were recently diagnosed, suggesting it is more common to seek out social support during 
the first 10 years from the time of diagnosis. Those attending the support groups did not 
have a strong correlation with growing up on the farm, even though studies have noted 
the risk of farming is associated with Parkinson’s disease and associated chemicals 
(Kenborg et al., 2012; Wright Willis et al., 2010). In this study, less than half of 
participants grew up on a farm. This may be explained because those farming possibly 
are less likely to attend support groups. Additionally, persons with Parkinson’s disease 
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who are still farming may have been too busy to attend the support groups in the fall, as 
data were collected during harvest time. 
Analysis of Multivariate Methods 
 Three multivariate methods were used in the analysis. The first method completed 
was the exploratory factor analysis (EFA), which extracts factors or dimensions from a 
large set of variables. Next, a confirmatory factor analysis (CFA) was used to determine 
and measure the goodness of fit of the factor structure for the sample data (Hair, Black, 
Babin, & Anderson, 2010). Finally, a path analysis was completed using AMOS 19.0 to 
measure the relationship between dependence, independent, and moderator variables 
(Munro, 2005). Tests were completed to analyze the assumptions of the path analysis.  
Factor Analysis 
            Exploratory factor analysis (EFA) clarifies how the observed items and latent 
variables are related to one another (Byrne, 2010). Using the EFA process, underlying 
factors or dimension among the selected input variables were extracted in the analysis. 
These dimensions were assumed to represent factors that are highly inter-correlated 
among the large variable set of survey items.  
Prior to running the factor analysis, the EFA assumptions were considered 
appropriate for use of the model. EFA assumptions or requirements includes sample size 
considerations, intercorrelation of the input variables, measure of sampling adequacy, 
total variance explained, average factor loading, measure of reliability, convergent and 
discriminate validity (Hair et al., 2010; Williams, 2012). According to Tinsley & Brown 
(2000), if these assumptions are not met, the power will be reduced and the chance of a 
Type 1 error is greatly increased. The recommended sample size should be 100 or larger 
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for factor analysis (Hair et al, 2010; Field, 2014). This study’s sample size, n =179, is 
appropriate for an EFA design. 
Factor rotation used in the study was an oblique rotation using Promax rotation. 
According to Portney & Watkins (2009) oblique rotation is easy to interpret and 
conceptually simple. Eigenvalues represented the amount of variance that belonged to a 
factor and was a statistic used as a cutoff point to limit the number of factors in the 
analysis. Only factors having eigenvalues greater than one are considered significant and 
values less than one are disregarded (Portney & Watkin, 2009). Finally, the scree-plot 
and factor loadings (correlations between the original variables and the factors) were 
examined using criteria of ±.30 threshold established by Hair et al (2010). Correlation 
coefficients over ±.30 are good indicators of factorability (Tabachnick & Fidell, 2007). 
Hair et al. (2010) describes EFA as a process that identifies representative 
variables from a much larger set of variables for use in subsequent multivariate analyses. 
EFA was completed in this analysis to help explain how the observed number of survey 
items related, 52 items on the HPLP-II scale, 8 items on the HRQOL scale, and 12 items 
on the hope scale, which equaled 72 total input variables. This large number of variables 
excluded the demographic profile questions.  
Extracted Factors 
The results of factor analysis extraction method identified seven dimensions: 
spiritual growth, HRQOL, health responsibility, physical activity, nutrition, and the 
combination of hope and HRQOL. A total of seven dimensions with eigenvalues greater 
than 1.0 were identified (see Table 7). This explains 55% of the cumulative variance of 
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the extracted factors from the data, which is well above the threshold for cutoff suggested 
by Hair et al. (2010). Examining the scree plot (see Figure 3) identified seven extracted 
factors, the line of the infliction point separates seven significant eigenvalues greater than 
1.0 from eigenvalues (below 1.0) that are not significant. Out of the 72 input variables 
selected for factor extraction, 42 input variables showed adequate factor loads to their 
respective factors. Average commonality (common variance) across the factors was .549, 
(see Table 8) which was higher than the .30 threshold established by Hair et al., (2010).  
 
 
Figure 3. Scree plot. 
  
64 
 
Table 7 
Total Variance Explained 
Extracted Factors 
Initial Eigenvalues 
Rotation Sums 
of Squared 
Loadings 
Total 
% of 
Variance 
Cumulative 
% 
Total 
Spiritual Growth (SG) 9.798 23.328 23.328 8.050 
Quality of Life (QOL) 3.300 7.858 31.185 4.172 
HOPE 3.114 7.415 38.601 5.949 
Health Responsibility (HR) 1.972 4.696 43.297 3.897 
Physical Activity (PA) 1.924 4.580 47.877 3.509 
Nutrition  1.600 3.810 51.687 3.024 
HOPE/QOL 1.554 3.699 55.386 2.808 
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Table 8 
 
Communalities of Factor Loadings___________________________________________ 
Factor                       Communality                           Factor                  Communality
HPLP18 0.757 
HPLP24 0.741 
HPLP12 0.649 
HPLP17 0.578 
HPLP23 0.543 
HPLP36 0.621 
HPLP30 0.575 
HPLP6 0.504 
HPLP19 0.588 
HPLP35 0.559 
HPLP39 0.579 
HPLP27 0.489 
HPLP15 0.480 
HPLP31 0.543 
HPLP51 0.478 
HPLP43 0.430 
HPLP10 0.645 
HPLP4 0.638 
HPLP28 0.553 
HPLP16 0.428 
HPLP46 0.416 
HPLP2 0.519 
HPLP8 0.483 
HPLP26 0.468 
HPLP44 0.463 
HPLP9 0.402 
HPLP20 0.540 
HOPE3 0.487 
HOPE6 0.352 
HOPE7 0.518 
HOPE8 0.600 
HOPE9 0.569 
HOPE11 0.735 
HOPE12 0.754 
RevQOL7 0.362 
RevQOL4 0.493 
RevQOL1 0.606 
RevQOL2 0.599 
RevQOL5 0.609 
RevQOL5 0.624 
RevQOL8 0.495 
RevQOL3 0.594 
Average 
Communalities             0.549
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Factor Loadings 
According to Hair et al. (2010), factor loadings are the correlation of the input 
variables within each extracted factor. Hair et al. established factor loading criteria with 
ranges from ±.30 to ±.40 to meet the minimal level for interpretation of structures 
(factors) and loadings ±.50 or greater are considered practically significant. Six of the 
seven extracted factors have average factor loadings greater than 0.50, which verifies the 
significance of the factor loadings within each of the structures (factors/dimensions) from 
the data set and one extracted factor in the combination of Hope/HRQOL had average 
loading less than the standard threshold. The hope/HRQOL combination dimension had 
an average factor loading= 0.419 (see Table 9). 
            Factor loading of each input variable to their respective factor or dimensions were 
measured. The spiritual growth dimension had an average factor loading = 0.81. HRQOL 
dimension had an average factor loading = 0.626. The hope factor had an average factor 
loading = 0.672. Health responsibility dimension had an average factor loading = 0.559. 
Nutrition dimension had an average factor loading = 0.538. 
In terms of the average loadings at the scale level, HPLP had an average factor 
loading = 0.598. Hope had an average factor loading = 0.672. HRQOL had an average 
factor loading = 0.522. All reached the threshold of 0.50 and so are considered 
significant.  
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Table 9 
 
  
Spiritual 
Growth
Quality of 
Life
Hope
Health 
Responsibility
Physical 
Activity
Nutrition Hope/QOL
Cronbach's Alpha (0.890) (0.784) (0.846) (0.770) (0.788) (0.735) (0.670)
HPLP24 0.819
HPLP18 0.749
HPLP23 0.731
HPLP35 0.674
HPLP30 0.663
HPLP12 0.625
HPLP36 0.552
HPLP17 0.541
HPLP6 0.520
HPLP19 0.406
Average Factor 
Loadings: 
0.628
RevQOL5 0.696
RevQOL1 0.681
RevQOL2 0.667
RevQOL6 0.655
RevQOL8 0.429
Average Factor 
Loadings: 
0.626
HOPE11 0.831
HOPE12 0.701
HOPE7 0.678
HOPE9 0.586
HOPE8 0.564
Average Factor 
Loadings: 
0.672
HPLP39 0.772
HPLP27 0.625
HPLP15 0.578
HPLP51 0.492
HPLP31 0.475
HPLP43 0.413
Average Factor 
Loadings: 
0.559
HPLP4 0.851
HPLP10 0.847
HPLP28 0.697
HPLP16 0.491
HPLP46 0.390
Average Factor 
Loadings: 
0.655
HPLP8 0.724
HPLP2 0.721
HPLP26 0.473
HPLP44 0.464
HPLP9 0.453
HPLP20 0.394
Average Factor 
Loadings: 
0.538
HOPE3 0.526
RevQOL7 0.407
RevQOL3 0.406
RevQOL4 0.396
HOPE6 0.358
Average Factor 
Loadings: 
0.419
Extraction Method: Maximum 
Likelihood. 
 Rotation Method: Promax with 
Kaiser Normalization. a
a. Rotation converged in 7 iterations.
Pattern Matrix: Dimension level
Factor
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The Goodness of Fit test concerning the terms of model fit of the extracted factor 
model (EFA) is found in Table 8. According to Hair et al. (2010), the measure of model 
fit using Chi- Square/Df of less than 3.0 is a sign of adequate fit. The study’s Chi-
Square/Df = 1.43 indicated a parsimonious fit of the model at the EFA stage (see Table 
10). 
Table 10 
Goodness-of-Fit Test________________ 
Chi-Square           df           Chi-Square/Df 
843.278                 588            1.43*_____ 
*Model Fit Threshold= <3 
Validation of the Extracted Factors 
            According to Portney and Watkins (2009), there are three steps to consider for the 
validation process of extracted factors. The first is to consider the discriminate validity, 
which analyzes whether the factors are distinct and uncorrelated. The second step 
evaluates the convergent validity, which assesses the degree to which two or more 
measures of the same concept are correlated. The final step checks the inter-item 
reliability, or the extent to which a variable or set of variables is consistent in what it is 
intended to measure.  
Discriminant Validity. The Factor Correlation Matrix (see Table 11) displays the 
correlation coefficients between the seven factors to test for discriminant validity. The 
table presents the relative measure of the strength of the relationship between the five 
extracted factors. Validation of the extracted factors should not be greater than the 
correlation coefficient of ±0.70 (Gaskin, 2012) to have discriminate validity. This 
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assumption of a correlation coefficient less than 0.70 relates to the issues with severe 
high correlation between two factors, which indicates that those factors’ individual 
contributions are reduced. Variables need to be distinct and uncorrelated to have validity. 
No bivariate correlation coefficient greater than 0.70 was shown after the inspection of 
the factor correlation matrix, which indicates that each of the extracted factors are distinct 
and this study shows discriminant validity was achieved.  
Table 11 
 Factor Correlation Matrix 
Factor SG QOL HOPE HR PA Nutrition HOPE/QOL 
SG 1 0.422 0.599 0.345 0.272 0.242 0.333 
QOL 0.422 1 0.197 0.085 0.268 0.144 0.128 
HOPE 0.599 0.197 1 0.402 0.239 0.165 0.230 
HR 0.345 0.085 0.402 1 0.189 0.232 0.062 
PA 0.272 0.268 0.239 0.189 1 0.343 -0.076 
Nutrition 0.242 0.144 0.165 0.232 0.343 1 -0.030 
HOPE/QOL 0.333 0.128 0.230 0.062 -0.076 -0.030 1 
 
           Similarly, bivariate correlations (see Table 12) between the three scales have 
shown no bivariate correlation greater than 0.70. Therefore, each of the three scales are 
distinct. This confirms that discriminant validity was achieved at the higher order.   
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Table 12 
 
Correlation Matrix between the 3 Scales 
  HPLP HOPE QOL 
HPLP 
Pearson 
Correlation 
1 .549** .458** 
Sig. (2-tailed)   0.000 0.000 
N 179 179 179 
HOPE 
Pearson 
Correlation 
.549** 1 .308** 
Sig. (2-tailed) 0.000   0.000 
N 179 179 179 
QOL 
Pearson 
Correlation 
.458** .308** 1 
Sig. (2-tailed) 0.00 0.00   
N 179 179 179 
 
Convergent Validity. According to Hair et al. (2010), the threshold for loadings 
should be greater than 0.5 to have sufficient loading, regardless of sample size. Average 
factor loadings for each of the two factors were greater than 0.50. Upon examination of 
Tables 9 and 10, six of the seven extracted factors have adequate factor loadings greater 
than expected threshold except the Hope/HRQOL combination. Overall, the indicator 
variables converged well together with their respective factors and convergent validity 
was achieved.  
Inter-Item Reliability. In exploratory research, Cronbach’s Alpha value above 
.70 is a good measure of inter-item level consistency (Hair et al., 2010). The inter-item 
reliability tests whether the extent variables or sets of variables are consistent in what it is 
intended to measure. This is different from validity of the extracted factors because it 
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does not relate to what should be measured, but rather instead to how it is measured (Hair 
et al., 2010).  
Another measure of reliability is internal consistency. This applies to the 
consistency among the variables in a summated scale. Internal consistency describes how 
the individual items or indicators of the scale should all be measuring the same construct 
and thus be highly inter-correlated (Byrne, 2010; Tinsley & Brown, 2000).  
The spiritual growth factor’s internal consistency was, α = .890. The HRQOL 
factor’s internal consistency was, α = .784. The hope factor’s internal consistency was, α 
= .846. The health responsibility factor’s internal consistency was, α = .770. The physical 
activity factor’s internal consistency was, α = .788. The nutrition factor’s internal 
consistency was, α = .735. The hope/HRQOL combination factor’s internal consistency 
was, α = .670.  This indicates that the individual items within each dimensions achieved a 
good level of internal consistency, and therefore achieved inter-item consistency. 
Confirmatory Factor Analysis (CFA). According to Field (2014), the CFA is an 
important step to test hypotheses and the relationships between the latent variables. This 
is important because these latent variables are related to variables that can be measured, 
but cannot be measured directly. Hair et al. (2010) describes three assumptions that need 
to be met for the CFA process. First, significance of the indicator variables to their 
respective factors or dimension must be established. Then model fit of the factor model. 
Lastly, reliability of the factor model is tested. 
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Figure 4. Confirmatory factor model diagram. 
Figure 4 is the diagram of the final confirmatory factor structure model. To 
achieve adequate model fit, modification indices (covariance of the error terms) offer 
remedies to discrepancies between the proposed and the estimated model and 
modification index value. Greater than 15.0 is a good indicator to covary the error terms 
of the same factor to improve model fit (Gaskin, 2012). 
Several error terms existed in the model. Each covaried terms have similar item 
structure and thus covarying their error terms was appropriate to improve goodness of 
fit. Additionally, six HPLP items (HPLP 8, 28, 20, 46, 10, and 51) were dropped 
because of their large residual errors between the proposed and estimated CFA model.  
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Covariation existed between the items listed below: 
1. HPLP item 15 “Question health professionals in order to understand their 
instructions” and HPLP item 39 “Ask for information from health 
professionals about how to take good care.”  
2. HPLP item 27 “Discuss my health concerns with health professionals” and 
HPLP item 39 “Ask for information from health professionals about how to 
take good care” also showed covariance.  
3. HPLP item 15 “Question health professionals in order to understand their 
instructions” and HPLP item 27 “Discuss my health concerns with health 
professionals.” 
4.  HPLP item 31 “Touch and am touched by people I care about” and HPLP 
item 43 “Get support from a network of caring people.” 
5.  HPLP item 4 “Follow a planned exercise program” and HPLP item 16 “Take 
part in light to moderate physical activity.” 
6. HPLP item 2 “Choose a diet low in fat, saturated fat, and cholesterol” and 
HPLP item 44 “Read labels to identify nutrients, fats, and sodium content in 
package food.”  
7. HRQOL item 5 “Had problems with concentration” and HRQOL item 6 “Felt 
unable to communicate with people properly.”  
8.  HRQOL item 1 “Had difficulty getting around in public” and QOL item 2 
“Had difficulty dressing myself.” 
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Table 13 
Regression Weights: CFA 
      Estimate S.E. C.R. P 
HPLP9 <--- HPLP 0.330 0.086 3.829 *** 
HPLP44 <--- HPLP 0.287 0.123 2.33 * 
HPLP26 <--- HPLP 0.298 0.095 3.154 ** 
HPLP2 <--- HPLP 0.223 0.101 2.214 * 
HPLP16 <--- HPLP 0.337 0.108 3.123 ** 
HPLP4 <--- HPLP 0.236 0.119 1.979 * 
HPLP43 <--- HPLP 0.342 0.097 3.529 *** 
HPLP31 <--- HPLP 0.544 0.086 6.32 *** 
HPLP15 <--- HPLP 0.321 0.105 3.057 ** 
HPLP27 <--- HPLP 0.307 0.097 3.168 ** 
HPLP39 <--- HPLP 0.472 0.103 4.597 *** 
HPLP19 <--- HPLP 0.731 0.089 8.188 *** 
HPLP6 <--- HPLP 0.782 0.098 7.981 *** 
HPLP17 <--- HPLP 0.642 0.081 7.955 *** 
HPLP36 <--- HPLP 0.858 0.089 9.683 *** 
HPLP12 <--- HPLP 1.009 0.095 10.568 *** 
HPLP30 <--- HPLP 0.959 0.106 9.089 *** 
HPLP35 <--- HPLP 0.848 0.099 8.556 *** 
HPLP23 <--- HPLP 0.837 0.098 8.567 *** 
HPLP18 <--- HPLP 1.101 0.095 11.617 *** 
HPLP24 <--- HPLP 
1 (Fixed 
parameter) 
~ ~ ~ 
RevQOL5 <--- QOL 
1 (Fixed 
parameter) 
~ ~ ~ 
RevQOL1 <--- QOL 1.118 0.23 4.861 *** 
RevQOL2 <--- QOL 0.958 0.215 4.448 *** 
RevQOL6 <--- QOL 1.033 0.144 7.152 *** 
RevQOL8 <--- QOL 1.003 0.203 4.931 *** 
HOPE3 <--- QOL 0.756 0.155 4.894 *** 
RevQOL7 <--- QOL 0.863 0.204 4.237 *** 
RevQOL3 <--- QOL 1.324 0.223 5.935 *** 
RevQOL4 <--- QOL 0.92 0.173 5.332 *** 
HOPE6 <--- QOL 0.628 0.147 4.27 *** 
HOPE11 <--- HOPE 
1 (Fixed 
parameter) 
~ ~ ~ 
HOPE12 <--- HOPE 1.156 0.083 13.899 *** 
HOPE7 <--- HOPE 0.589 0.073 8.043 *** 
HOPE9 <--- HOPE 0.711 0.083 8.541 *** 
HOPE8 <--- HOPE 0.844 0.085 9.889 *** 
***p <.001, ** p<.01, *p<.05 
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Regression weights (see Table 13) for each of the indicator variables were 
manifested by their respective factors. Three fixed parameters (not estimated) were 
needed to find model convergence or model solution of the maximum likelihood 
algorithm. Each of the regression weights were statistically significant. This confirms that 
the model structure proposed by the study is satisfactory. Table 14 describes measures of 
model fit, using Hu and Bentler (1999) conventions of goodness-of-fit indices. This 
three-factor model structure achieved adequate and reasonable model fit. The extracted 
factors provided the study with a robust factor model, which was used in the study’s 
hypothesis-testing stage. The construct reliability of the confirmed factor structure model 
is shown to have an adequate inter-item consistency greater than the standard threshold 
value of 0.70, QOL = .792, HPLP = .857, and hope = .844 (see Table 15). 
Table 14  
 
Model Fit Indices 
  Acceptable Thresholds  
Observed 
Model Fit 
CMIN/DF Between 2-5* 1.74 
CFI > .95 great; > .90 traditional; > .80 
permissible * 
0.82 
RMR < .07* 0.06 
RMSEA < .05 good; .05 - .10 moderate; > .10 
bad* 
0.07 
*Hu and Bentler (1999)   
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Table 15 
Construct Reliability 
QOL          0.792 
HPLP        0.857 
HOPE        0.844___ 
Threshold= >0.70 
            After meeting the assessment of the reliability test, convergent validity, 
discriminant validity, and confirmation of model fit of the factor model, a summated 
scale or a composite variable was created. This scale combined each of the survey items 
or indicator variables to their respective factors to facilitate the statistical calculation of 
the hypothesized path models. The three composite variables were used to test for the 
five assumptions of the multivariate regression method to assess for appropriateness of 
method used.  
Path Analysis (Multivariate Regression) Assumptions 
The first assumption tested if normal distribution existed among the input 
variables. Next, the assumption was tested to see if the model was unidirectional, having 
a linear relationship between the dependent and independent variables. Multicollinearity 
was also tested in order to determine whether extreme correlations between independent 
variables were present. Assumptions of homogeneity/homoscedasticity were then 
evaluated to assess if the residual variances of Y (outcome) were equally the same for the 
level of X (predictors). Finally, independent of errors or residual terms were tested (Hair 
et al., 2010; Munro, 2005). 
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Normality. The first assumption examined whether the input variables estimated normal 
distribution visually. Pictures of histograms and boxplots determined influential outliers. 
Shapiro-Wilk’s test of normality is a conservative test for normal distribution. The test 
was conducted to approximate normality and observe skewness and kurtosis values 
against an accepted threshold value (Field, 2014). 
 Figure 5 displays the histograms with the fitted normal curve. Examination of the 
histogram graph for dependent variable, HRQOL, shows the spread of the distribution 
has an asymmetric shape with a slight negative or left-skewed distribution, or left tail. 
Similarly, the predictor variable hope displays an asymmetric distribution with a slight 
negative or left skewed as evidence of the extended left tail. Lastly, the independent 
variable HPLP appears to depict a symmetric distribution with equal lengths of the right 
and left tails of the curve.  
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       i. QOL                                                                                 ii. HOPE 
   
           iii. HPLP                
 
Figure 5. Histograms with fitted curves.  
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Outlier Detection  
                              
 
i. QOL                                                         ii. HOPE 
 
 
 
 
     iii. HPLP  
               
Figure 6. Boxplots. 
Examination of the boxplots (see Figure 6) notes the presence of influential 
outliers detected in both the HRQOL and hope variables. Several cases below the 
minimum level of the bottom 25% of the HRQOL and hope scores were evident. Outliers 
were not significant for the HPLP variable. 
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Table 16 
Summary of Statistics 
  QOL HOPE HPLP 
N 179 179 179 
Mean 2.592 3.081 3.423 
Std. Deviation 0.503 0.480 0.640 
Skewness -0.521 -0.379 -0.275 
Std. Error of 
Skewness 
0.182 0.182 0.182 
Skewness Ratio -2.863 -2.082 -1.511 
Kurtosis 0.068 0.256 -0.593 
Std. Error of 
Kurtosis 
0.361 0.361 0.361 
Kurtosis Ratio 0.188 0.709 -1.643 
 
Examination of the summary statistics (see table 16) shows the input variables 
and skewness/kurtosis estimations. The dependent variable, HRQOL, showed a negative 
skewed distribution (skewness statistic = -0.521) and had a positive kurtosis value 
(kurtosis statistic = 0.068). This indicated a very slight evidence of distribution with 
peaked distribution characteristics. The independent variable, hope, had a negative 
skewed distribution (skewness statistic = -0.379), and its kurtosis had a positive kurtosis 
value (kurtosis statistic = 0.256), which also indicated evidence of distribution with 
peaked distribution characteristics. The independent variable, HPLP, displayed a slight 
negative skewed distribution (skewness statistic = -0.275) and had a negative kurtosis 
value (kurtosis statistic = -0.593) indicated as evidence of platykurtic or with distribution 
with flat distribution characteristics. Warner (2013) suggested that skewness and kurtosis 
values of -1 to +1 are considered ideal, whereas values ranging from -2 to +2 are 
considered acceptable. Following this convention guideline by Warner (2013) suggests 
each of the input variables demonstrated normal distribution. 
81 
 
Table 17 
 
Test of Normality 1 
  
Shapiro-Wilk 
Statistic df Sig. 
HOPE 0.937 179 0.000 
QOL 0.975 179 0.003 
HPLP 0.982 179 0.020 
*. This is a lower bound of the true 
significance. 
   
a. Lilliefors Significance Correction 
   
 
 
For the Shapiro-Wilk’s test of normality, an S-W value of 1.0 and a non-
significant p-value designates the given data is perfectly normal (Tabachnick & Fidell, 
2007). The Shapiro-Wilk’s test of normality (see Table 17) notes that the dependent 
variable, HRQOL, S-W(179) = 0.975, p < .05, and  S-W value much closer to 1.0. This 
significant p-value indicated that approximation to normality was violated or the current 
data was not normally distributed according to the S-W convention.  
The independent variable, hope, S-W(179) = 0.937, p < .05, with an S-W value 
close to 1.0 but a significant p-value, indicates that the approximation to normality was 
violated. The independent variable, HPLP, S-W(179) = 0.982, p < .05, with an S-W value 
closer 1.0 but a significant p-value, indicates that the approximation to normality was 
violated. Overall, the results from the Shapiro-Wilk test have revealed that each of the 
input variables have violated the normality assumption.  
In conclusion, the sample data revealed the three input variables demonstrated to 
have achieved normal distribution. According to the conventions of observed skewness 
and kurtosis, values against an accepted threshold value (±1.0), and the skewness and 
kurtosis ratio test were met. Although the Shapiro-Wilk’s test of normality did indicate 
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violation to normality, the attained S-W values for each of the three input variables were 
much closer to the value of 1.0 as a barometer of perfect normal distribution according 
(Tabachnick & Fidell, 2007) standards.  
Linear Assumptions. Examination of the scatterplot matrix (see Figure 7) reveals 
a bivariate relationship of each of the two independent variables in Hope and HPLP. The 
scatterplots also show a bivariate relationship of the moderator variable disease severity 
(with five levels) to the dependent variable, HRQOL. The scatterplot matrix graph 
demonstrates adequate linearity. 
  
 
 
Figure 7. Scatterplot matrix.  
 
 
Multicollinearity Assumption. Hair et al. (2010) describe multicollinearity as 
when any single independent variable is highly correlated (r > .70) with a set of other 
independent variables. High multicollinearity among variables lessens an individual 
variable’s unique variance.  
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According to Hair et al (2010), tolerance values should be above 10. Tolerance 
describes the amount of an independent variable’s predictive capability that is not 
predicted by other independent variables in the equation. Tolerance values less than .10 
lead to multicollinearity examination. A multicollinearity test among independent 
variables is called the Variance Inflation Factor (VIF). According to Field (2014), VIF 
values above 5.0 are good indicators of high multicollinearity. Inspection of the 
multicollinearity test (see Table 18) has revealed that independent variables in HOPE, 
HPLP, and Disease Severity had observed that tolerance values and VIF values were 
within the threshold standard. This indicated that problematic high correlation between 
the above predictors and moderator variables were not an issue. Therefore, 
multicollinearity problems between the independent variables are no concerns for this 
study.  
Table 18 
 
Multicollinearity Test of Variables 
Model 
Collinearity Statistics 
Tolerance VIF 
  
HPLP 0.376 2.662 
HOPE 0.382 2.615 
Disease 
Severity 
0.966 1.035 
a. Dependent 
Variable: QOL 
   
 
 
 Equality of Variances. Levene’s Test of Homogeneity of Variances (see Table 19) 
tests whether the variances between independent groups are equal (Field, 2014). The null 
hypothesis states that the variances across independent groups are equal, which indicates 
that any p-values significance above a set significance level have met the assumption of 
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equal variances. Using a significance level of .05, the moderator variable with five 
categorical levels/groups with p-values significance greater than the .05 level, the Levene 
Statistic = 1.756, p > .05, indicates that the error variances across the five groups are 
approximately equal from each other. Therefore, homogeneity of variances was assumed.  
Table 19 
Test of Homogeneity of Variances 
QOL   
Levene 
Statistic 
df1 df2 Sig. 
1.756 4 174 0.140 
 
Another similar test of homogeneity of variances, the test of homoscedasticity or 
heteroscedasticity, is the Breusch-Pagan test of homoscedasticity. According to 
Tabachnick and Fidell (2007), this test investigates whether the standardized residuals 
against the predicted values are random. The Breusch-Pagan test detects any 
heteroscedasticity, or whether error variances are equal between independent variables 
(continuous or interval scale). 
Table 20 
Test of Heteroscedasticity of Variances (Breusch-Pagan Test) 
  
Chi-Square 
value Df Sig 
2 predictor variables (HOPE & HPLP) and 
one moderator variable(Disease Severity) 
2.759 179 0.430 
 
The Breusch-Pagan test of heteroscedasticity (see Table 20), using a non-
significance value of p > .05, suggested that the error variance between the two time 
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points are approximately equal from each other. Upon examination of the table, the three 
independent variables had a non-significant outcome, X2 (179) = 2.759, p > .05. This 
indicates that the error variances between the three independent variables are statistically 
equal to each other, and therefore meets the assumption of equality of variances.  
 Independence of Error Terms. According to Hair et al. (2010), multiple 
regression models assumed that each predicted value is independent, and that means that 
the predicted value is not related to any other predicted values. Thus, values do not have a 
systematic pattern that influences the predicted values from each other.  
Additionally, Hair et al. (2010) recommends another diagnostic test to examine 
the histogram, normal Q-Q plot, scatterplots, boxplots of the residual terms, and the 
Shapiro-Wilk test of normality to determine whether non-normality of error terms are 
present. This comprehensive test is the Mahalanobis Distance (D2) test, which considers 
only the distance of an observation from the mean values of the independent variables 
and not impact the predicted value (Hair et al., 2010). The D2 test is another way to 
identify outliers.  
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  i. Histogram with fitted curves                            ii. Normal Q-Q Plot 
                            
iii. Boxplot                                                       iv. Scatterplot: Residual terms  
                                                                              by predicted values 
Figure 8. Visual inspection of the residual terms (errors). 
An examination of Figure 8, specifically the histogram and the boxplot, reveals 
apparent symmetry of both the right and left tails of the distribution, which indicates 
normality of the residual terms. No systematic pattern influences the predicted values 
from each other. Even though the boxplots reveal data points outside the top and bottom 
25% of the residual error scores, the normal distribution curve is not distorted. The 
diagonal line of the normal Q-Q plot shows a measure of normality. Data in this plot 
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points to the residual terms. Clusters above or below the line suggest that auto-correlation 
of the error terms were not present in the sample data. Additionally, an examination of 
the scatterplot between the residual terms and predicted values shows that the model’s 
predicted values indicated random occurrences between predicted and errors. No 
systematic patterns were detected. The Shapiro-Wilk test of normality (see Table 21) also 
confirmed that the distribution of the residual terms are normally distributed, S-W (179) = 
.989, p > 0.05.  
Table 21 
 
Test of Normality 2 
  
Shapiro-Wilk 
Statistic df Sig. 
Standardized 
Residual 
0.989 179 0.197 
*. This is a lower bound 
of the true significance. 
   
a. Lilliefors Significance 
Correction 
   
 
        A Mahalanobis D (D2) test was conducted using df = 3 (2 independent variables and 
1 moderator variable), and the p-value of .01 criterion at which a Chi-Square (X2) value 
of 11.34 constitutes as the threshold value to determine whether such residual errors were 
within acceptable limits; values greater than 11.34 indicates residual errors with non-
random occurrences. Table 22 below had revealed 2 cases (ID# 170 and 45) and the 
subsequent Mahalanobis distance values for each observation did exceed such threshold 
and thus these 2 cases were excluded from the data analysis, and thus, sample size, n = 
177. For model verification, a hypothesized model with the full sample (median imputed) 
will be compared to the hypothesized model with 2 cases removed to verify the model’s 
stability.   
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Table 22 
Case Summaries 
  ID 
Mahalanobis 
Distance 
1 170 15.558 
2 45 12.876 
3 79 10.901 
4 58 10.228 
5 100 9.300 
6 171 8.815 
7 96 8.488 
8 55 8.357 
9 174 7.827 
10 176 7.601 
11 158 7.569 
12 137 7.480 
13 90 6.894 
14 164 6.780 
15 84 6.571 
Total N* 15 15 
*Limited to 15 cases   
 
Summary of Path Analysis Assumptions 
In conclusion, the current sample data, along with the input variables, have 
demonstrated to have met the five path analysis assumption tests of the multiple 
regression model. Therefore, the path analysis was the appropriate statistical model to 
estimate the overall regression and assess the direct and moderator effects of the 
hypothesized model.   
Research question 1. What is the level of hope in persons with Parkinson’s 
disease? Persons with Parkinson’s disease identified a high level of hope. The level of 
hope ranged from 16 to 48. Two cases that had significant outliers were removed. Table 
24 shows the average hope scores with two cases removed (n = 177), M = 16.565 and a 
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standard deviation, SD = 2.261. In other words, at one standard deviation, the spread of 
hope scores range from 14.304 to 18.826. For full sample data (n = 179), hope scores had 
an average, M = 16.480 and a standard deviation, SD = 2.385. At one standard deviation, 
the spread of hope scores ranges from 14.095 to 18.865 at the full sample.     
Analysis of Question 1. A one-sample t-test (see Table 23) shows that the 
difference in hope scores between the study’s current sample data (N = 177, M = 16.565, 
SD = 2.261) and the hypothesized cut-off HOPE score value (M=12.50) were statistically 
significant. Statistics for the current sample test include t (176) = 23.922, p = .000, 95% 
CI [3.730, 4.400] with a large effect size, Cohen’s d = 1.80 and a post-hoc statistical 
power of 1.00. 
 For the full sample data (N = 179, M = 16.480, SD = 2.385), the difference from 
hypothesized cut-off hope score value (M=12.50) were statistically significant, t (178) = 
22.327, p = .000, 95% CI [3.629, 4.332]. The sample had a large effect size, Cohen’s d = 
1.67 and a post-hoc statistical power of 1.00.  
Table 23 
 
One-Sample Test Hope Hypothesized Value of the Mean 
  
Test Value = 12.50 (Hypothesized value)   
t df 
Sig. (2-
tailed) 
Mean 
Difference 
    
95% C.I 
Lower 
95% C.I. 
Upper 
HOPE(2 cases 
removed) 
23.922 176 0.000 4.065 3.730 4.400 
HOPE (Full 
sample) 
22.327 178 0.000 3.980 3.629 4.332 
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Hope was also tested using the top third of the hope scale with a test value of 15. 
According to Herth, some researchers using her tool have considered the lower third of 
the scores as low hope and the upper third of the scores as high hope (personal 
communication, February 19, 2017). The upper one third of the hope scores for the 
current study’s sample was considered 15. The test value for the upper third cut off was 
tested to see if the t-test for hope showed stability. The t-test for hope (two cases removed 
for outliers) shows the study’s sample data (N= 177, M =1.56) (see Table 24). The upper 
third cut-off increases stability, as it is statistically significant for hope, t (176) = 9.21, p 
= .000, 95% CI [1.230, 1.90]. The sample had a large effect size, Cohen’s d = 1.80 and a 
post-hoc statistical power of 1.00. A t-test was also completed to compare the means of 
hope and gender. Females were found to have a slightly higher level of hope, M = 17.03, 
SD= 2.18, versus men who had a mean level of hope, M = 16.27, SD= 2.27 (see Table 
25). In addition, a correlation was run to compare hope to age. Hope did not show a 
significant correlation to the participant’s age (N = 177, r = .057, p= 0.45) (see Table 26). 
Table 24 
One-Sample Test Hope 1/3 Cut Off   
 
Test Value = 15 (Upper 1/3 cut off)   
t df 
Sig. (2-
tailed) 
Mean 
Difference 
    
95% C.I 
Lower 
95% C.I. 
Upper 
HOPE 9.21 176 0.000 1.560 1.230 1.900 
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Table 25 
 
 
 
 
 
Table 26 
Correlations of Age 
  Age 
HOPE_Hypo1 Pearson 
Correlation 
-
.057 
Sig. (2-
tailed) 
.452 
N 177 
 
Summary  
In conclusion, the study rejected the null hypothesis for question one; there is no 
difference in the level of hope between groups. There is sufficient evidence to support the 
study’s assumptions. This suggests that the hope scores of the current sample population 
is significantly higher compared to both the cut-off value of the hypothesized mean in the 
population and the top third of the scores from the Hope scale used in this sample. 
  
Group Statistics for Hope and Gender 
Gender N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
HOPE_Hypo1 Female 69 17.0290 2.17588 .26194 
Male 108 16.2685 2.27381 .21880 
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Research question 2. What is the relationship between hope and health-
promoting behaviors on HRQOL in persons with Parkinson’s disease?  
 
Figure 9. Conceptual diagram of the hypothesized path model. 
 
Analysis of Question 2.  Examination of Table 27 shows the average HRQOL 
scores (n = 177) was, M = 28.853 and a standard deviation, SD = 6.179 with the lowest 
observed minimum score, Min = 9.0 and maximum score, Max = 40.0. At one standard 
deviation, the spread of QOL measure ranges from 22.674 to 35.032. The HOPE scale 
had an average score, M = 16.565 and standard deviation, SD = 2.261 with the lowest 
observed minimum score, Min = 11.0 and maximum score, Max = 20.0. At one standard 
deviation, the spread of the HOPE measure ranges from 14.304 to 18.826. Lastly, the 
HPLP scale had an average score of M = 58.729 and standard deviation of SD = 9.441, 
with the lowest observed minimum score, Min = 33.0 and maximum score, Max = 83.0. 
At one standard deviation, the spread of the HPLP measure ranges from 49.288 to 
68.170.  
  
 
 
             
 
 
 
       
Health Promoting 
Behaviors 
Hope 
Quality of Life 
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Table 27 
 
Descriptive Statistics 
  QOL HOPE HPLP 
N 177 177 177 
Mean 28.853 16.565 58.729 
Median 29 16 59 
Std. Deviation 6.179 2.261 9.441 
Skewness -0.512 0.025 -0.146 
Std. Error of 
Skewness 
0.183 0.183 0.183 
Kurtosis 0.066 -0.944 -0.231 
Std. Error of 
Kurtosis 
0.363 0.363 0.363 
Minimum 9 11 33 
Maximum 40 20 83 
 
The hypothesized model had an observed coefficient of determination of R2 = 
.620, and an Adj. R2 = .615 (see Table 28). Hope was entered first into the regression 
based on the theoretical influences hope has on health-promoting behaviors. When both 
explanatory variables of HOPE and HPLP were entered in the model, about 62% of the 
variation of scores within the dependent measure in HRQOL was explained. Therefore, 
HRQOL could be predicted by both predictor variables in the model. Overall, the 
hypothesized regression model has a large effect size, which indicates that the level of 
associations between the predictors and the outcome variable were large. Thus, 38% of 
variance could be from factors other than the two explanatory variables presented in the 
model. 
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Table 28 
Model Summary_________________________________________________ 
                                                           Change Statistics                                      Change Statistics 
                                    Adjusted         Std Error of          R square          F                df1      df2          Sig F       Dutbin- 
Model     R Square       R Square        the Estimate         Change          Change                                  Change    Watson 
1 0.328 0.324 0.404 0.328 85.405 1 175 0.000  
2 0.620 0.615 0.305 0.292 133.415 1 174 0.000 1.995 
a. Predictor variables: Hope 
b. Predictor variables: Hope, HPLP  
c. Dependen variable: QOL 
 
Analysis of coefficients table (see Table 29) shows that the HPLP was a 
significant predictor of HRQOL while accounting for the direct effect of HOPE measure 
in the model, t = 11.551, p < .001, 95% C.I. [0.553, 0.781]. The positive slope for HPLP 
as a predictor of HRQOL indicated that there was a 0.667 (Beta coefficient) increase in 
HRQOL measure for each increase in HPLP levels, while controlling for the effect of 
HOPE measure in the model.  
Using the Squared Partial Correlation, approximately 43% of the variance in 
HRQOL measure was uniquely estimated by HPLP while accounting for the effect of 
hope measure. Explanatory variable in hope was not a significant predictor of HRQOL 
measure while accounting for the direct effect of HPLP measure in the mode, t = -1.078, 
p > .05, 95% C.I. [-0.243, 0.071]. Observed statistical power of the hypothesized model 
was 1.0 or 100% detection rate of avoiding a Type II error.  
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Table 29 
 
Coefficients Table 
Model   
Unstandardized 
Coefficients 
  
Standardized 
Coefficients 
t Sig. 
95.0% 
Confidence 
Interval for 
B 
    
    B 
Std. 
Error 
Beta     
Lower 
Bound 
Upper 
Bound 
Partial 
1 (Constant) 0.675 0.211   3.201 0.002 0.259 1.091   
  HOPE 0.622 0.067 0.573 9.242 0.000 0.489 0.755 0.573 
2 (Constant) 0.573 0.159   3.599 0.000 0.259 0.888   
  HOPE -0.086 0.080 -0.079 -1.078 0.282 -0.243 0.071 -0.081 
  HPLP 0.667 0.058 0.846 11.551 0.000 0.553 0.781 0.659 
a. Dependent variable: QOL 
Lastly, comparisons between path models using a non-CFA-adjusted path model 
against CFA-adjusted path model reveals the CFA adjusted remarkably improved 
goodness of fit (see Table 30) of the hypothesized path model. According to Hair et al. 
(2010), the lower values of Akaike Information Criterion (AIC), from 1130.165 to 86.758 
and Bayesian Information Criterion (BIC) from 1142.91 to 99.46 are indicative for good 
measures of model fit.  
Table 30 
Model Fit Comparison: Non-CFA Adjusted vs CFA Adjusted 
  AIC BIC 
Non-CFA adjusted Path Model 1130.165 1142.914 
CFA adjusted Path Model 86.758 99.463 
Summary 
In conclusion, the study rejects the null hypothesis for question two; there is not a 
relationship between hope, health promoting behaviors, and HRQOL. There was 
sufficient evidence to support the assumption, which claims that there were at least one of 
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the two explanatory variables that were statistically significant in predicting the variation 
of HRQOL scores while controlling the direct effects of both explanatory variables.  
HPLP was a significant predictor of HRQOL. However, HOPE was not a significant 
predictor of HRQOL measure while accounting for the direct effect of HPLP (see Figure 
10). 
 
Figure 10. Final path analysis model for Hypothesis 2.  
The hypothesized model had an observed coefficient of determination of R2 = .62. 
This means that together, hope and HPLP explained about 62% of the variation of scores 
within the dependent measure in HRQOL. Hope becomes non-significant with the 
inclusion of HPLP.  
Research question 3. What is the relationship among hope, health-promoting 
behaviors, HRQOL, and disease severity? 
Analysis of Question 3. For the path analysis, a multiple regression method used 
a total of four input variables. There were two variables assigned as independent 
variables, or predictors: i) HPLP = a scale variable with an interval measurement, and ii) 
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HOPE = a scale variable with an interval measurement. One variable was assigned as a 
moderator variable: iii) Disease Severity = a categorical variable with an ordinal 
measurement (1= Stage 1, 2= Stage 2, 3 = Stage 3, 4 = Stage 4 & 5 =Stage 5). Lastly, one 
criterion variable was assigned as a dependent variable; or criterion iv) HRQOL = a scale 
variable with interval measurement. For the one sample t-test method, one variable was 
assigned, HOPE, as the dependent variable and its median value as the test value. The 
total sample size was n= 179. 
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Table 31 
 
Path Model Summary of the Multi-Group Effects 
Model 
Bivariate 
Correlation 
of IV's 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
R-
Squared 
B 
Std. 
Error 
Beta 
Stage 
1 
QOL 
<---
HOPE 
0.695 
-0.142 0.144 -0.141 
-
0.983 
n.s. 
0.626 
QOL 
<---
HPLP 
0.721 0.117 0.883 6.138 *** 
Stage 
2 
QOL 
<---
HOPE 
0.862 
-0.222 0.227 -0.251 
-
0.980 
n.s. 
0.705 
QOL 
<---
HPLP 
0.699 0.171 1.047 4.081 *** 
Stage 
3 
QOL 
<---
HOPE 
0.789 
-0.021 0.108 -0.021 
-
0.197 
n.s. 
0.603 
QOL 
<---
HPLP 
0.570 0.077 0.793 7.442 *** 
Stage 
4 
QOL 
<---
HOPE 
0.766 
-0.506 0.265 -0.576 
-
1.911 
0.056 
0.489 
QOL 
<---
HPLP 
0.752 0.219 1.034 3.431 *** 
Stage 
5 
QOL 
<---
HOPE 
0.717 
0.049 0.211 0.044 0.230 n.s. 
0.761 
QOL 
<---
HPLP 
0.655 0.148 0.840 4.415 *** 
 
Stage 1’s impact on the hypothesized model produced a large coefficient of 
determination, R2 = 0.626, and the explanatory variable in HPLP was significant in the 
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hypothesized path model, t (4, 174) = 6.138, p < .001 (see Table 31). Stage 2’s impact on 
the hypothesized model also produced a large coefficient of determination, R2 = 0.705, 
and the explanatory variable in HPLP was significant in the hypothesized path model, t 
(4, 174) = 4.081, p < .001. Stage 3’s impact on the hypothesized model produced a large 
coefficient of determination, R2 = 0.603, and the explanatory variable in HPLP was 
significant in the hypothesized path model, t (4, 174) = 7.442, p < .001. Stage 4’s impact 
on the hypothesized model produced a coefficient of determination, R2 = 0.489, and the 
explanatory variable in HPLP was significant in the hypothesized path model, t(4, 174) = 
3.431, p < .001. Finally, Stage 5’s impact on the hypothesized model produced a large 
coefficient of determination, R2 = 0.761, and the explanatory variable in HPLP was 
significant in the hypothesized path model, t(4, 174) = 4.415, p < .001.  
A Chi-Square difference test was conducted to test whether the five stages of 
disease severity moderated the direct effects between the two explanatory variables in 
hope and HPLP to the criterion variable in HRQOL measure. The result from the Chi-
Square test of the multi-group moderation models was not significant, X2(8) = 5.936, p = 
.654. This indicated that there were no differences between the five stages of severity 
given the hypothesized path model. Therefore, there was no evidence of moderating 
effects of the varying stages of disease severity on the direct effects of hope and HPLP to 
the criterion variable in HRQOL measure.  
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Table 32 
 
Model Fit Indices: Multi-group Moderation 
  Acceptable Thresholds  
Observed 
Model Fit 
GFI 
> .95 great; > .90 
traditional; > .80 
permissible * 
0.98 
AGFI 
> .95 great; > .90 
traditional; > .80 
permissible * 
0.92 
RMR < .07* 0.02 
RMSEA < .05 good; .05 - .10 
moderate; > .10 bad* 
0.00 
*Hu and Bentler 
(1999)   
 
Table 32 is a measure of model fit using Hu and Bentler (1999) conventions of 
goodness-of-fit indices. The five level multi-group moderation models appears to achieve 
adequate and reasonable model fit. This confirms that hypothesized moderated model 
parsimoniously fits the characteristics of the sample data. 
Summary  
In conclusion, the study failed to reject the null hypothesis. There is not a 
relationship between hope, health promoting behaviors, and HRQOL while  
controlling for disease severity. There was not sufficient evidence to support the 
assumption, which claims that there were moderating effects of varying stages of disease 
severity and its relation to the direct effects of hope and HPLP to the dependent measure 
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in HRQOL. 
  
Figure 11. Final path analysis model for Hypothesis 3.  
 
The hypothesized model had an observed coefficient of determination of R2 = .67. 
This means that together, hope, HPLP, and disease severity explained about 67% of the 
variation of scores within the dependent measure in HRQOL. The path model suggested 
that the HRQOL means between the five disease severity stages were different. However, 
no difference was detected between the five disease severity stages for both hope and 
HPLP.  Therefore, no moderating effect of disease severity could be examined.  
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CHAPTER 5: SUMMARY OF FINDINGS 
Introduction 
The purpose of this research was to examine the relationships between the 
concepts of hope, health-promoting behaviors, and HRQOL in persons with Parkinson’s 
disease. This chapter discusses the study outcomes, strengths, limitations, and 
implications for nursing practice.  
Summary of Findings 
The participants of the study were from a convenience sample of Parkinson’s 
disease support groups, the South Dakota Parkinson’s Foundation, and the Midwest 
Parkinson’s Foundation mailing list. The average age of the study participant was 73 
years.  Sixty percent of persons in the study were male, which relates to Parkinson’s 
disease being slightly higher in men than women. The majority of participants were 
Caucasian and married. Over half of participants were diagnosed within the last five 
years. Less than half of the participants grew up on a farm.  
Research Questions. The literature and Stuifbergen’s Explanatory Model of 
Health-Promotion and Quality of Life for Persons with Chronic Conditions helped 
develop questions related to health-promoting behaviors, HRQOL, and disease severity. 
The hope-related question was derived from nurse researcher inquiry.  
Research Question 1: What is the level of hope in persons with Parkinson’s 
disease? The findings of Research Question 1 were significant. The range of scores was a 
minimum score of five and a maximum score of 20. The hope mean was at 16.57. The 
sample mean (N = 177, M = 16.565, SD = 2.261) was statistically different and 
significantly higher compared to the hypothesized population mean (M=12.50). The 
upper one third of the hope scale, hope value equal to 15, was also significant, p = .000. 
103 
 
Hope was noted to be significantly higher for women, but no significant difference was 
noted for hope related to age. Overall, findings are substantiated that persons with 
Parkinson’s disease have a high level of hope compared to both the test value of the 
hypothesized population mean and the top third of the scores from the Hope scale used in 
this sample.  
Research Question 2: What is the relationship between hope and health-
promoting behaviors on HRQOL in persons with Parkinson’s disease? The findings 
of Research Question 2 were significant. Multiple linear regression analysis identified 
that hope was a statistically significant predictor variable of HRQOL. However, the 
analysis found that when disease severity and health-promoting behaviors were added to 
the regression, hope was no longer a statistically significant predictor of HRQOL.  
This analysis identified health-promoting behaviors as a significant predictor to 
HRQOL. Multiple studies by Stuifbergen established an association between health-
promoting behaviors and a strong HRQOL (Stuifbergen, 1995; Stuifbergen & Rogers, 
2005; Stuifbergen, Seraphine, Harrison, & Adachi, 2004). Fowler (1997) noted a positive 
relationship between hope and health-promoting behaviors in persons with Parkinson’s 
disease.  
Research Question 3: What is the relationship among hope, health-
promoting behaviors, HRQOL, and disease severity? The findings of Research 
Question 3 were not significant (more likely due to the unequal and small sample size for 
Stages 2, 4, and 5). Multiple regressions were conducted in a structural equation 
modeling format. According to the path analysis, disease severity has a moderating effect 
as it directly influences the relationship between hope, health-promoting behaviors, and 
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HRQOL. At disease severity stage 4 of Parkinson’s disease, both hope and health-
promoting behaviors were significant predictors of HRQOL. Hope was not significant in 
predicting HRQOL at the rest of the stages, but health-promoting behaviors were 
predictors of HRQOL at all disease severity stages. The major drawbacks of this model 
were that the sample size was small and uneven for the five stages of disease severity. 
Without the inclusion of health-promoting behavior in this path model, hope is a 
significant predictor of HRQOL.  
According to the nursing literature, hope has a positive contribution to HRQOL 
(Rustoen, 1995; Farran et al., 1995). However, when accounting for the effects of the 
health-promoting behaviors in this study, hope becomes non-significant, which indicates 
that health-promoting behaviors modify the relationship. This is the first study to create 
an association between health-promoting behaviors, HRQOL, and hope in people with 
Parkinson’s disease.   
Implications for Nursing Practice 
         Parkinson’s disease is a health concern that is expected to double by 2030 and triple 
by 2050 (NPF, 2015). The growth of this disease will impact nurses who provide care for 
those with this progressive disease. Patient outcomes and HRQOL may improve if nurses 
design nursing interventions to improve hope and health-promoting behaviors, which in 
turn supports HRQOL. In addition, nurses have an important role to raise awareness 
about gaps in resources and advocate for policy development like the Cures Law that can 
help develop new treatments. Nurses can use research to collaborate with lawmakers to 
work together to create legislation that benefits those with Parkinson’s disease. Nurses 
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can also work with other clinicians to build evidence for funding to make devices, like a 
DBS, more commonplace.  
Findings for Research Question 1 pronounced the significance of hope in the lives 
of persons with Parkinson’s disease. Hope is essential to the story of human life. Persons 
with chronic illness are able to apply hope to overcome daily struggles and live a better 
life. At the end stage of disease, hope allows persons to die with dignity. Yet nurses lack 
an understanding of patients’ hope (Chi, 2007). Although hope is recognized as an 
important human need, some nurses lack skills and the time needed to provide critical 
emotional support. Advanced practice nurses can develop guidelines to assess hope, 
maintain hope, and provide strategies to implement hope. Nurse educators can advance 
the professional role of the nurse by teaching nursing students concepts of hope and hope 
interventions. Nurses can collaborate with their patients to discover meaningful hope-
building activities. 
The results of Research Question 2 calls on nurses to help patients implement 
health-promoting behavior strategies. Health-promoting behaviors were correlated with a 
strong HRQOL. Together hope, HPLP, and disease severity explained about 67% of the 
variation of scores for HRQOL. Advance practice nurses can gain insight related to 
methods of health-promoting behaviors for those with Parkinson’s disease and identify 
environments that lead to health-promoting behaviors. Better health-promoting behaviors 
are crucial to help those with chronic illness maintain independence and quality of life 
(Parcel, Barlett, Bruhm, 1986; Stuifbergen, 1995; Stuifbergen & Rogers, 2005; 
Stuifbergen et al., 2004).   
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The findings of Research Question 3 are pertinent to nursing practice for many 
reasons. The mean for HRQOL was different based on the levels of disease severity. 
However, the means for both hope and HPLP were not different, based on the levels of 
disease severity. Therefore, nurses have the opportunity to implement nursing 
interventions for hope and HPLP for all persons at various stages of Parkinson’s disease. 
Participating in hope intervention groups has been a positive experience for persons with 
cancer (Rusteon, Wiklund, Hanestad, & Moum, 1998; Herth, 2001). However, no hope 
intervention program exists for persons with Parkinson’s disease. Advance practice 
nurses could implement a hope intervention program for their patients in the hospital or 
for persons attending support groups. The hope intervention program would be based on 
strategies to improve the level of hope by doing exercises that produce hope. Herth 
(2001) has used activities such as making a hope mantel, hope journaling, hope tapes, 
hope drawings, hope energy saving baskets, joy collages, hope kits, hope memory books, 
and other activities to engender hope.  
Nurses can use patient education as an avenue to increase hope and health-
promoting behaviors. Incorporating hope-improvement strategies could be seen as part of 
activities of daily living (ADLs). Nurses could add to their ADL checklist incorporate 
hope strategy. This activity could be derived from surveying nurses or having focus 
groups generate ideas for strategies to improve hope. Patients could also be surveyed and 
asked, “Did your nurse enable hope for you today? If yes, please explain.” Exploring 
features of hope related to the patient experience can help identify behaviors that 
encourage attributes of hope. Similar activities could be used to incorporate health 
promotion as part of daily patient education. Nurse and patient collaboration can improve 
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the level of hope and health behaviors. Advance practice nurses can research hope 
strategies by asking patients and those with chronic illness questions that lead to 
constructive nursing care guidelines for hope and health-promoting behavior 
interventions.  
Stuifbergen’s Explanatory Model of Health-Promoting Behaviors within 
Chronic Conditions. The findings of this study support the conceptualization of 
Stuifbergen’s Explanatory Model of Health Promoting Behaviors within Chronic 
Conditions. Disease severity and hope influenced the concepts of health promotion and 
quality of life. Having hope and health-promoting behaviors can help persons with 
Parkinson’s disease better manage symptoms that influence quality of life.  
The research findings altered the hypothesized relationships of the study variables 
(see Figure 11). Hope was a statistically significant predictor variable of HRQOL. 
However, when health-promoting behaviors were added to the regression, hope was no 
longer a statistically significant predictor of HRQOL. Hope has a direct effect on 
HRQOL, and hope also was modified when HPLP was added to the regression. Together, 
hope and HPLP explained about 62% of the variation of scores within the dependent 
measure in HRQOL. Health-promoting behaviors are a significant predictor to HRQOL. 
There was not sufficient evidence to support the assumption, which claims that there 
were moderating effects of varying stages of disease severity and its relation to the direct 
effects of hope and HPLP to the dependent measure in HRQOL. 
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Figure 12. New model for variables: hope, health-promoting behaviors and HRQOL. 
Implications for Theoretical Framework 
According to Stuifbergen & Rogers (1997), an increase in disease severity 
parallels with an increase in barriers. Mobility, anxiety, depression, and pain are barriers 
impacting HRQOL that the PDQ-8 measured in this study.  Stuifbergen’s theory notes 
that health-promoting behaviors lessen the impact severity that illness has on impairing 
quality of life. Other variables that were prominent in Stuifbergen’s theory include self-
efficacy, resources, and acceptance 
Severity of Illness. In this study, high disease severity correlated with much 
worse quality of life. The persons in the study with the highest level of disease severity 
had the lowest quality of life. According to Stuifbergen’s framework, when severity of 
illness increases, barriers will likely increase. Some studies suggest that having 
Parkinson’s disease increases the risk of developing Lewy Body Dementia (LBD) 
(Dolhun, 2015; Todorova, Jenner, & Chaudhuri, 2014). A handful of participants wrote 
on the survey that they had LBD. This is the second-most progressive form of dementia 
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and involves proteins, called Lewy bodies, clumping together in the brain (Mayo Clinic, 
2017). The persons with LBD were noted to have high disease severity scores and low 
scores on quality of life.  
The results of this study partially support Stuifbergen’s theoretical model. This 
study found that health-promoting behaviors were a statistically significant predictor of 
HRQOL t = 11.551, p < .001, 95% C.I. [0.553, 0.781]. The results of disease severity on 
HPLP is not a significant predictor of HRQOL. There was not a difference in relationship 
between the five stages of disease severity on health-promoting behaviors or hope. The 
result from the Chi-Square test was not significant, X2(8) = 5.936, p = .654. Therefore, 
there was not moderation of the varying stages of disease severity on the direct effects of 
hope and HPLP on HRQOL. Nonetheless, significant results suggested a difference for 
HRQOL between the five stages of disease severity F (4, 172) = 17.821, p < .001. 
Barriers. Participants with Parkinson’s disease also encountered fatigue, pain, 
sleep problems, and bladder problems, which are major barriers that will increase severity 
of illness and therefore decrease HRQOL (Lou, 2015; Kadastik-Eerme, Rosenthal, Paju, 
Muldmaa, & Taba, 2015). Depression, anxiety, and decline in cognitive impairment in 
Parkinson’s disease are possible barriers that could result in lower HRQOL (Welsch et 
al., 2003).  
Self-Efficacy. Health-promoting behaviors improve with self-efficacy (Strecher et 
al., 1986; Stuifbergen & Becker, 1994). Self-efficacy and social cognitive theory 
(Bandura, 1997) describe health promotion starting with a goal, and for a person with 
Parkinson’s disease, that goal for health behavior begins with forming a lifestyle habit to 
help cope with the disease. Having these good habits can help improve the quality of life. 
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Resources. Stuifbergen (1995) described social support as one key resource. 
People who attend support groups were the key participants in the study and made up the 
majority of the population surveyed for this study. Attending a support group is a good 
resource of social support. Surveying those that attend a support group may have higher 
social support levels than those who did not participate in this study and are isolated from 
support groups. In the rural state where the study took place, several persons may not 
have access to a support group as a resource. At some of the support group meetings, the 
nurse researcher noted that some attendants drove up to 45 minutes to an hour to attend.  
Stuifbergen (1995) also noted income as a critical resource. A handful of persons 
in this study noted that when they had undergone a DBS procedure, their quality of life 
improved greatly. Hence, DBS may have lessened disease severity and had a positive 
impact on HRQOL for these participants. In a meta-analysis of six randomized controlled 
trials (n = 1,184), significant improvement in motor symptoms and higher quality of life 
after DBS procedure was reported (Perestelo-Pérez et al., 2014). Advocating for 
insurance coverage to help lessen the costs a DBS would benefit those who qualify for 
this device.  
Acceptance. The phase of Stuifbergen’s model before health-promoting 
behaviors is acceptance. The concept is significant for people with Parkinson’s disease 
because it helps with coping. Kubler-Ross (1969) describes acceptance as the last stage of 
grief. Persons with Parkinson’s disease must live in the space between accepting that 
there is no cure for the chronically progressive disease and the space where they hope for 
a cure. For many persons with chronic diseases, this space leads to health-promoting 
behaviors.  
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Strengths of the Study 
Theoretical definitions and frameworks guide this study. The conceptual 
definition of hope created by Dufault and Martocchio’s (1985) was operationalized in the 
questions of the HHI tool. The other conceptual definitions and tools relate. The study 
protected against bias by having an adequate sample size of 179 persons with Parkinson’s 
disease.  
Instruments. Prior studies established a high amount of reliability and validity 
for the three instruments used. This study also identified a high degree of reliability and 
validity for the instruments. Measures of model fit for the three-factor model structure 
was achieved. The robust factor model used in the study’s hypothesis testing stage was a 
strength of the study.  
Construct reliability of the confirmed factor structure model showed an adequate 
inter-item consistency greater than the standard threshold Cronbach’s Alpha value of 
0.70, HRQOL = .792, HPLP = .857, and hope = .844. The HHI is a useful tool to assess 
hope in persons with Parkinson’s disease. The PDQ-8 is a useful tool to assess HRQOL 
in people with Parkinson’s disease. 
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Limitations of the Study  
The descriptive correlational design used by this study does not report causality 
but rather describes the relationships of the study variables (Polit & Beck, 2012). The size 
of the sample was sufficient until it was broken down into the disease severity stages. The 
sample size may be a limitation particularly related to Research Question 3, which breaks 
down the sample into smaller groups based on disease severity. The non-significant 
results to Research Question 3 may have been different had a larger sample been 
available. A possible strong moderating effect of hope and health-promoting behaviors on 
HRQOL may be noted in future studies with a larger sample.  
The majority of the sample was a convenience sample of persons who participated 
in support groups who were in early stages of Parkinson’s disease. Research by Herth on 
hope and quality of life in persons with cancer does not measure hope in the first five 
years since diagnosis of disease because the shock of new diagnosis may skew results 
(Herth, 1989). Including those in this study that were recently diagnosed could be a 
limitation. The sample was predominantly Caucasian, lacking ethnic diversity, which is 
an additional limitation of the study. Selecting persons who were in support groups may 
be a barrier to true representation of health-promoting behaviors, as these persons have 
established a connection of social support. Data for health-promoting behaviors may be 
skewed for this study because participants were selected from a support group and thus 
are more inclined to exhibit health-promoting behaviors versus the general population.  
Although evidence suggests that pesticides increase the risk of Parkinson’s 
disease, this study did not find a connection between agriculture and Parkinson’s disease. 
Less than half the participants were from agriculture backgrounds. However, some of the 
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persons from agriculture backgrounds may have not been represented because the 
majority of data collection was during the fall harvest months.  
Another limitation is that persons self-report the stage of the disease, which may 
misjudge the disease severity. Disease severity can lead to fatigue, and the surveys were 
long, especially for persons with Parkinson’s disease who may struggle with small 
handwriting. Survey fatigue is an additional limitation of this study. A possible limitation 
may be having participants who had early-stage dementia and did not know it. The two 
surveys that were discarded for outliers had the highest level of disease severity stage 5, 
and it was noted on the survey that the participants had LBD. 
The HPLP-II questionnaire was long, having 52 items. Six HPLP items were 
dropped during the EFA stage because of large residual errors in order to get adequate 
validity, reliability, and model fit. Survey fatigue could have contributed to limitations 
of the study and problem with errors accounted for with the HPLP scale.    
Recommendations for Future Study 
Health-Related Quality of Life. James Parkinson’s (1817) landmark Essay on 
the Shaking Palsy first noted impairments on quality of life from Parkinson’s disease 200 
years ago. This classic study discovered the signs and symptoms for the disease, but 
history has not yet provided a cure. Therefore, advances to increase the quality of life, 
despite disease progression, are pertinent. Drug therapy has made little improvement 
since the discovery of Sinemet (carbidopa-levodopa) in the early 1960s.This drug 
remains the treatment of choice to improve mobility in persons with the disease. 
However, this drug also causes many possible side effects, such as daytime sleepiness, 
somnolence, dyskinesia, confusion, hallucinations, and compulsive behaviors (Merck 
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Sharp & Dohme Corp, 2014). Taking drugs to improve motor symptoms for some 
persons with Parkinson’s disease can be a double-edged sword because the side effects of 
the drug can also decrease HRQOL.  
Health-Promoting Behaviors Related to Nutrition. Research for a new 
medicine being developed includes a possible more natural remedy using turmeric, an 
herb commonly used in Indian food, as a component of a neuroprotective drug. 
According to Mythri and Bharath (2012), turmeric is made of curcumin, which has great 
antioxidant and anti-inflammatory effects, and contains other neuroprotective properties 
that cross the blood-brain barrier. This spice has long been used as healing therapies for 
not only neuroprotective, but also cardiovascular, gastrointestinal, and hepatoprotective, 
and other inflammatory issues in Chinese and Ayuvedic systems of medicine 
(Monograph, 2001). Future research could include a randomized control trial 
implementing dietary changes to include turmeric and the effect on symptoms. 
Hope and Health-Promoting Behavior Intervention Studies. Nurses can play a 
significant role in influencing hope and health-promoting behaviors for persons with 
Parkinson’s disease. Intervention studies to promote hope and health behaviors for 
persons with Parkinson’s disease are needed. Hope interventions and health-promoting 
behaviors may support HRQOL of an ongoing nature. Persons will be introduced to 
concepts of hope and health-promoting behaviors as part of their daily routines. Support 
groups and conferences for persons with Parkinson’s disease could be the setting for 
future intervention studies.    
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Conclusion  
This descriptive correlational study examined the relationship between hope, 
health-promoting behaviors, quality of life, and disease severity in persons with 
Parkinson’s disease. Stuifbergen’s Explanatory Model of Health-Promoting Behaviors 
within Chronic Conditions guided the study. Research findings from the study on hope, 
health-promoting behaviors, health-related quality of life, and disease severity in persons 
with Parkinson’s disease and implications for nursing practice were discussed. Strengths 
and limitations of the conceptual framework were analyzed. The implications of the study 
and recommendations for future studies related to hope, health-promoting behaviors, and 
health-related quality of life were examined. 
The study generates new nursing knowledge on hope and health-promoting 
behaviors for persons with Parkinson’s disease. The study identified a relationship 
between hope, health-promoting behaviors, and quality of life. These important findings 
indicate that hope is beneficial to quality of life. Health-promoting behaviors are 
statistically significant predictors of health-related quality of life. The increased 
knowledge will raise awareness on the importance of hope and health-promoting 
behaviors for persons with chronic diseases like Parkinson’s disease.  
This study represents an innovative starting point for future studies implementing 
hope interventions and health-promoting behaviors. Despite advancing disease severity 
and the crippling effects of Parkinson’s disease, hope and health-promoting behaviors 
predict quality of life. The result of hope interventions and health promoting behaviors in 
persons with Parkinson’s disease is a catalyst leading to improved quality of life, not only 
for those afflicted with the disease, but also their families.   
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Appendix A 
 
Demographic instrument for background information 
1. Participant age _________ 
2. Gender: 
_____Male 
_____Female 
3. Marital status 
_____Single, never married 
_____Married 
_____Divorced 
_____Separated 
_____Widowed 
_____In a relationship, but not married 
4. Ethnicity 
_____White 
_____Native American 
_____Hispanic 
_____Asian-Pacific Islander 
_____African American 
5. Length of time since diagnosis____________  
6. Did you grow up on a farm/ranch?  
______Yes 
______No 
7. Length of time on a farm/ranch_________ 
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Appendix B 
Hoehn and Yahr Stages of Parkinson’s Disease Scale 
Stage 01 Symptoms on one side only 
Stage 02 Symptoms on both sides without balance 
impairment 
Stage 03 Mild to moderate disease, some postural 
instability, physically independent 
Stage 04 Severe disease, able to walk or stand 
unassisted 
Stage 05 Wheelchair bound or bedridden unless 
assisted 
 
The following statement best describes my symptoms, when I feel at my best: (check 
one)                        
q1 I have symptoms on the one side of my body only 
q2 I have symptoms on both sides of the body, but my balance is not affected   
q3 I have mild to moderate symptoms on both sides of the body, and my balance is 
somewhat affected, but I am physically independent  
q4 My symptoms are severe, but I am still able to stand and walk without help 
q5 I cannot get out of the bed or up from a chair unless somebody helps me
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Appendix C 
Health-Promoting Lifestyle Profile (HPLP) II  
 
DIRECTIONS:  This questionnaire contains statements about your present way of life or personal habits. Please respond to each item 
as accurately as possible, and try not to skip any item. Indicate the frequency with which you engage in each behavior by circling: 
N for never, S for sometimes, O for often, or R for routinely 
 
 
1. Discuss my problems and concerns with people close to me. N S O R 
2. Choose a diet low in fat, saturated fat, and cholesterol. N S O R 
3. Report any unusual signs or symptoms to a physician or other health professional. N S O R 
4. Follow a planned exercise program. N S O R 
5. Get enough sleep. N S O R 
6. Feel I am growing and changing in positive ways. N S O R 
7. Praise other people easily for their achievements. N S O R 
8. Limit use of sugars and food containing sugar (sweets). N S O R 
N
E
V
E
R
 
S
O
M
E
T
I
M
E
S
 
O
F
T
E
N
 
R
O
U
T
I
N
E
L
Y
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9. Read or watch TV programs about improving health. N S O R 
10. Exercise vigorously for 20 or more minutes at least three times a week (such as 
brisk walking, bicycling, aerobic dancing, using a stair climber). 
N S O R 
11. Take some time for relaxation each day. N S O R 
12. Believe that my life has purpose. N S O R 
13. Maintain meaningful and fulfilling relationships with others. N S O R 
14. Eat 6-11 servings of bread, cereal, rice and pasta each day. N S O R 
15. Question health professionals in order to understand their instructions. N S O R 
16. Take part in light to moderate physical activity (such as sustained walking 30-40 
minutes 5 or more times a week). 
N S O R 
17. Accept those things in my life which I can not change. N S O R 
18. Look forward to the future. N S O R 
19. Spend time with close friends. N S O R 
20. Eat 2-4 servings of fruit each day. N S O R 
21. Get a second opinion when I question my health care provider's advice. N S O R 
22. Take part in leisure-time (recreational) physical activities (such as swimming, 
dancing, bicycling). 
N S O R 
23. Concentrate on pleasant thoughts at bedtime. N S O R 
24. Feel content and at peace with myself. N S O R 
25. Find it easy to show concern, love and warmth to others. N S O R 
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26. Eat 3-5 servings of vegetables each day. N S O R 
27. Discuss my health concerns with health professionals. N S O R 
28. Do stretching exercises at least 3 times per week. N S O R 
29. Use specific methods to control my stress. N S O R 
30. Work toward long-term goals in my life. N S O R 
31. Touch and am touched by people I care about. N S O R 
32. Eat 2-3 servings of milk, yogurt or cheese each day. N S O R 
33. Inspect my body at least monthly for physical changes/danger signs. N S O R 
34. Get exercise during usual daily activities (such as walking during lunch, using 
stairs instead of elevators, parking car away from destination and walking). 
N S O R 
35. Balance time between work and play. N S O R 
36. Find each day interesting and challenging. N S O R 
37. Find ways to meet my needs for intimacy. N S O R 
38. Eat only 2-3 servings from the meat, poultry, fish, dried beans, eggs, and nuts 
group each day. 
N S O R 
39. Ask for information from health professionals about how to take good care of 
myself. 
N S O R 
40. Check my pulse rate when exercising. N S O R 
41. Practice relaxation or meditation for 15-20 minutes daily. N S O R 
42. Am aware of what is important to me in life. N S O R 
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43. Get support from a network of caring people. N S O R 
44. Read labels to identify nutrients, fats, and sodium content in packaged food. N S O R 
45. Attend educational programs on personal health care. N S O R 
46. Reach my target heart rate when exercising. N S O R 
47. Pace myself to prevent tiredness. N S O R 
48. Feel connected with some force greater than myself. N S O R 
49. Settle conflicts with others through discussion and compromise. N S O R 
50. Eat breakfast. N S O R 
51. Seek guidance or counseling when necessary. N S O R 
52. Expose myself to new experiences and challenges. N S O R 
Scoring Instructions 
Items are scored as Never (N) = 1, Sometimes (S)= 2, Often (O) = 3, Routinely (R) = 4 
A score for overall health-promoting lifestyle is obtained by calculating a mean of the individual's responses to all 52 items; six 
subscale scores are obtained similarly by calculating a mean of the responses to subscale items. The use of means rather than sums of 
scale items is recommended to retain the 1 to 4 metric of item responses and to allow meaningful comparisons of scores across 
subscales. The items included on each scale are as follows: 
Health-Promoting Lifestyle 1 to 52  
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Health Responsibility 3, 9, 15, 21, 27, 33, 39, 45, 51  
Physical Activity 4, 10, 16, 22, 28, 34, 40, 46  
Nutrition 2, 8, 14, 20, 26, 32, 38, 44, 50  
Spiritual Growth 6, 12, 18, 24, 30, 36, 42, 48, 52  
Interpersonal Relations 1, 7, 13, 19, 25, 31, 37, 43, 49  
Stress Management 5, 11, 17, 23, 29, 35, 41, 47 
 
(Walker, Sechrist, & Pender, 1995).  
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Appendix D 
Herth Hope Index (HHI) 
 
HERTH HOPE INDEX 
Listed below are a number of statements. Read each statement and place an [X] in the 
box that describes how much you agree with that statement right now. 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
 1. I have a positive outlook toward life.     
 2. I have short and/or long range goals.     
 3. I feel all alone.     
 4. I can see possibilities in the midst of 
difficulties. 
    
 5. I have a faith that gives me comfort.     
 6. I feel scared about my future.     
 7. I can recall happy/joyful times.     
 8. I have deep inner strength.     
 9. I am able to give and receive caring/love.     
 10. I have a sense of direction.     
 11. I believe that each day has potential.     
212  12. I feel my life has value and worth.     
(Herth, 1989)
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SCORING INFORMATION FOR THE HERTH HOPE INDEX (HHI) 
 
Scoring consists of summing the points for the subscale and for the total scale. Subscales 
are based on the three factors (see Table 2 in 1992 publication). Total possible points on 
the total scale is 48 points. The higher the score the higher the level of hope.  
Note the following items need to be reversed scored: 3, 6. Score items as follows:  
Strongly Disagree = 1  
Disagree = 2  
Agree = 3  
Strongly Agree = 4  
HHI has been translated into Brazilian, Chinese, Dutch, Filipino, French, German, 
Icelandic, Italian, Japanese, Korean, Norwegian, Portuguese, Slovenian, Spanish, 
Swedish, Tai, Turkish, Urdu.  
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Appendix E 
Parkinson’s Disease Quality of Life Questionnaire-8 (PDQ-8) 
 
Due to having Parkinson’s disease, how often during the past month have you….. Please 
tick one box for each question 
Never Occasionally Sometimes Often Always or 
cannot do 
at all 
 1. Had difficulty getting 
around in public? 
     
 2. Had difficulty dressing 
yourself? 
     
 3. Felt depressed?      
 4. Had problems with your 
close personal relationships? 
     
 5. Had problems with your 
concentration, e.g. when 
reading or watching TV? 
     
 6. Felt unable to communicate 
with people properly? 
     
 7. Had painful muscle cramps 
or spasms? 
     
 8. Felt embarrassed in public 
due to having Parkinson’s 
disease 
     
(Jenkinson & Fitzpatrick, 2007)
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Appendix F 
 
Pre-Notice Study Letter 
 
Given to prospective participants at conference or mailed to their home; first study 
contact. 
 
April 23. 2016 
 
First Last Name 
Address 
City, State, Zip Code 
 
Dear First Last Name, 
 
I am writing to ask for your help with an important study investigating health-promoting 
behaviors, hope, and health-related quality of life experienced by persons with 
Parkinson’s. Within the next week, you will receive another letter asking you to 
participate in this study. The letter will contain surveys related to your level of health-
promoting behaviors, hope, and quality of life. 
The reason I am writing in advance is because I want you to have time to think about 
participating in my study. I would like to make it an easy and enjoyable process. This 
study is part of my dissertation. I am a doctoral student at South Dakota State University 
and the study has been approved by the SDSU Nursing Research Committee and the 
Office of Research/Human Subjects Committee.  
 
Please consider taking 15-20 minutes of your time to help with the study. I would like 
you to have the opportunity to add your perspective on health-promoting behaviors, hope 
and health-related quality of life.  
Sincerely, 
 
Amy K. Forbes, MS, RN 
PhD Student 
South Dakota State University 
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Appendix G 
 
First Letter Contact 
 
Sent to prospective participants; second study contact 
 
Dear First Name, 
 
Recently you received a letter asking you to respond to study surveys regarding health-
promoting behaviors, hope, and quality of life. Your response to these surveys is helpful 
to further understanding of these concepts in nursing practice. 
The survey has several components, but should only take you about 15 to 20 minutes to 
complete. Please see enclosed surveys. 
 
Everything is kept confidential in this study and no personally identifiable information 
will be associated with responses. Your participation is completely voluntary. Please feel 
free to contact me at akpeterson1277@jacks.sdstate.edu or my dissertation chair 
Kay.Foland@sdstate.edu 
 
I appreciate your help in considering to complete the surveys. Thank you for 
participating. 
 
Sincerely, 
 
Amy K. Forbes, MS, RN 
PhD Student 
South Dakota State University 
 
Dr. Kay Foland, PhD, RN, PMHNP-BC, PMHCNS-BC, CNP 
Professor 
South Dakota State University College of Nursing, West River 
Rapid City, SD 
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Appendix H 
Thank You Letter Contact 
Sent to prospective study participants; third study contact 
Dear First Name, 
 
During the last week you were sent surveys regarding the concepts of health-promoting 
behaviors, hope, and quality of life. I hope that you have taken the time to complete the 
surveys. Please consider taking 15-20 minutes to complete the surveys now. I appreciate 
all your help for this important study.  
 
Thanks again for your participation. 
 
Sincerely, 
 
Amy K. Forbes, MS, RN 
PhD Student 
South Dakota State University 
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Appendix I 
Permission Emails 
3/28/2016 
Hi Amy: 
You have my permission to use the Health Promoting Life Style II instrument or any 
other instruments that seem useful. 
Please see attachment with Deep Blue website with the instrument and instructions. 
 
Wishing you good health, 
Nola Pender 
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Appendix J 
Permission Emails 
 
6/17/2016 
Dear Amy, 
I appreciate your continued interest in the Herth Hope Index (HHI).  I have attached a 
copy of the HHI, scoring instructions, and two reference lists I have compiled on hope 
primarily from the nursing discipline. 
 
You have my permission to use the HHI in your dissertation research project exploring 
hope, health-promoting behaviors and HRQOL in persons with Parkinson's Disease. I ask 
that you send me a summary of your study findings upon completion of the project. 
 
Best wishes in your educational journey and your important research study. 
Sincerely, 
Dr. Kaye Herth  
 
Kaye A. Herth, Ph.D., R.N., F.A.A.N. 
Minnesota State University, Mankato 
Dean Emerita 
kaye.herth@mnsu.edu 
 
  
 
 
 
